≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Dementia, including avohilmo

EFO Endpoint Browser PheWeb

F5_DEMENTIA_INCLAVO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — F00-F09

1 out of 7 registries used, show all original rules.

10401

4. Check minimum number of events

None

10401

5. Include endpoints

27454

6. Filter based on genotype QC (FinnGen only)

27454

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 426237 260291 161598
Only index persons 319065 198585 120480
Unadjusted period prevalence (%)
Whole population 6.31 7.46 4.52
Only index persons 6.28 7.30 4.60
Median age at first event (years)
Whole population 80.83 81.81 79.31
Only index persons 81.04 82.03 79.39

-FinnGen-

Key figures

All Female Male
Number of individuals 27454 12583 14871
Unadjusted period prevalence (%) 5.52 4.29 6.56
Median age at first event (years) 78.96 79.37 78.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
8199
Matched controls
73416
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N06DA03
ATC
rivastigmine; oral, transdermal
364.8
323.0
1903
61
N05AX08
ATC
risperidone; systemic
10.6
323.0
1491
1501
G30.8
ICD-10 Finland
Other Alzheimer disease
116.5
323.0
659
55
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
+∞
323.0
701
*
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
+∞
323.0
1184
*
A28
ICPC
Limited function/disability NOS
4.2
323.0
2531
7081
G30.1
ICD-10 Finland
Alzheimer disease with late onset
116.5
323.0
2278
242
SPAT1216
SPAT
Assessment of functional ability
3.7
323.0
2539
7967
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.6
323.0
1421
2641
N06DX01
ATC
memantine; oral
599.7
323.0
3073
72
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
323.0
946
*
P20
ICPC
Memory disturbance
13.0
323.0
4071
5175
F03
ICD-10 Finland
Unspecified dementia
+∞
323.0
1959
*
N06DA04
ATC
galantamine; oral
390.0
323.0
829
21
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
145.5
323.0
924
64
N05AH04
ATC
quetiapine; oral
4.8
323.0
1898
4363
N06DA02
ATC
donepezil; oral
343.2
323.0
3148
133
SPAT1245
SPAT
Provision of support and information to patient’s family members
9.1
323.0
1056
1174
G30
ICD-10 Finland
Alzheimer disease
120.6
323.0
373
29
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
+∞
323.0
482
*
P70
ICPC
Dementia
66.2
323.0
630
92
F06.7
ICD-10 Finland
Mild cognitive disorder
12.7
323.0
816
634
SPAT1053
SPAT
Memory test
5.9
323.0
3799
9412
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
9.8
323.0
2432
3036
G30.0
ICD-10 Finland
Alzheimer disease with early onset
279.1
323.0
468
16
SPAT1234
SPAT
Support of social functional capacity
6.3
322.4
941
1474
F01.9
ICD-10 Finland
Vascular dementia, unspecified
+∞
314.7
313
*
TAB00
NOMESCO Finland
Lumbar puncture
7.3
314.0
825
1114
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
5.7
308.9
986
1726
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.1
307.0
2112
7428
AA1AD
NOMESCO Finland
CT of head and brain
2.6
302.8
3051
13597
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
+∞
279.2
278
*
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
272.2
271
*
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
271.2
270
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
6.3
262.0
757
1158
R41.3
ICD-10 Finland
Other amnesia
7.3
258.4
672
886
R53
ICD-10 Finland
Malaise and fatigue
2.7
252.9
2172
8639
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
241.0
2044
8034
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
+∞
240.9
240
*
XA800
NOMESCO Finland
Neuropsychological investigation
6.4
232.1
667
1008
SPAT1254
SPAT
Administration of medicine
2.8
223.6
1742
6462
L28
ICPC
Limited function/disability (L)
2.6
217.2
1970
7978
N03AG01
ATC
valproic acid; systemic, rectal
5.0
216.1
759
1459
G20
ICD-10 Finland
Parkinson disease
5.6
211.2
670
1144
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
206.0
2973
15134
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
5.9
202.4
618
1005
R41.0
ICD-10 Finland
Disorientation, unspecified
6.9
200.6
539
739
N06AX11
ATC
mirtazapine; oral
2.1
183.5
2837
14695
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.3
181.8
1054
3160
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
170.3
170
*
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
+∞
166.3
166
*
N05AH03
ATC
olanzapine; systemic
4.7
164.2
609
1230
N87
ICPC
Parkinsonism
8.9
161.2
366
384
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
147.9
1371
5474
N05BA04
ATC
oxazepam; oral
2.1
147.8
2177
10834
SPAT1229
SPAT
Assessment of need for aid
2.8
143.0
1044
3625
N06AB10
ATC
escitalopram; oral
2.4
142.6
1426
5917
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
11.8
141.7
276
216
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.0
140.6
913
2936
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.3
138.8
777
2245
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.0
132.3
462
871
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
127.1
127
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.6
123.4
605
1572
F05.9
ICD-10 Finland
Delirium, unspecified
7.0
123.3
325
430
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
+∞
123.1
123
*
N06AX26
ATC
vortioxetine; oral
4.4
121.9
477
1011
A04
ICPC
Weakness/tiredness general
2.3
120.2
1253
5262
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
118.1
118
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
116.5
892
3165
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
115.4
1749
8664
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.0
115.1
736
2328
A06AD11
ATC
lactulose; oral
2.2
114.9
1416
6424
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
35.8
114.0
153
39
F05.1
ICD-10 Finland
Delirium superimposed on dementia
115.4
112.9
127
10
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
7.5
112.8
283
348
SPAT1301
SPAT
No procedures
1.8
111.8
3081
18772
SPAT1172
SPAT
Guidance concerning hydration
5.4
110.6
354
603
N04BD01
ATC
selegiline; oral
6.7
108.7
296
410
WYA20
NOMESCO Finland
Home visit
10.0
108.3
229
211
Z2445
NOMESCO Finland
Psychologist
4.9
108.2
379
715
F00
ICD-10 Finland
Dementia in Alzheimer disease
+∞
108.0
108
*
G31.0
ICD-10 Finland
Circumscribed brain atrophy
20.9
107.8
167
73
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
107.7
685
2155
SPAT1101
SPAT
Orthostatic test
3.2
107.1
622
1836
SPAT1304
SPAT
Counselling and guidance related to ageing
2.5
106.1
920
3495
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
+∞
105.0
105
*
F01
ICD-10 Finland
Vascular dementia
+∞
104.0
104
*
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
9.4
103.0
225
220
N05BA06
ATC
lorazepam; systemic, sublingual
3.3
103.0
580
1673
N06AB04
ATC
citalopram; systemic
1.9
102.8
1771
9158
F01.2
ICD-10 Finland
Subcortical vascular dementia
+∞
101.0
101
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.4
100.7
394
833
109
Kela drug reimbursment
Multiple sclerosis
16.1
99.1
168
95
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.1
98.9
1336
6263
G35
ICD-10 Finland
Multiple sclerosis
9.0
96.9
216
219
SPAT1360
SPAT
Extensive global examination
2.4
95.3
875
3418
U04
ICPC
Incontinence urine
3.1
94.0
582
1790
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
93.0
93
*
SPAT1252
SPAT
Overall medication plan or its review
2.5
92.9
824
3155
N05AD01
ATC
haloperidol; systemic
4.7
92.4
338
667
G04BD12
ATC
mirabegron; oral
2.0
89.3
1253
5945
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
88.2
1231
5823
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
86.0
86
*
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
18.7
84.9
136
66
A29
ICPC
General symptom/complaint other
2.1
84.8
1100
5042
I95.1
ICD-10 Finland
Orthostatic hypotension
3.5
84.8
438
1180
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
84.3
485
1417
S06.0
ICD-10 Finland
Concussion
2.3
84.2
874
3620
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
83.5
2048
11793
S01.0
ICD-10 Finland
Open wound of scalp
2.5
83.2
736
2808
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.4
82.3
773
3041
N04BD02
ATC
rasagiline; oral
8.5
82.0
189
203
R42
ICD-10 Finland
Dizziness and giddiness
1.7
77.5
2028
11862
S72.0
ICD-10 Finland
Fracture of neck of femur
3.4
73.7
380
1021
SPAT1246
SPAT
Screening of depression or other psychiatric problem
4.2
73.0
295
642
R55
ICD-10 Finland
Syncope and collapse
2.0
72.6
1088
5262
N03AE01
ATC
clonazepam; systemic
2.6
72.6
590
2144
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
6.1
72.4
209
313
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.0
72.1
997
4669
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.2
71.4
288
626
SPAT1167
SPAT
Insertion of urinary catheter
3.1
71.1
422
1258
AXX01
SPAT
NA
5.1
70.9
236
420
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.7
70.0
252
489
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.6
68.9
255
509
W19
ICD-10 Finland
Unspecified fall
2.1
68.4
830
3673
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
68.0
1190
6081
Z02.7
ICD-10 Finland
Issue of medical certificate
2.5
67.0
555
2034
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
66.3
2822
18584
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
66.3
703
2924
193
Kela drug reimbursment
Rasagiline
8.0
65.1
155
176
N06AX16
ATC
venlafaxine; oral
2.0
64.7
896
4188
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
4.9
64.4
223
415
N02BE01
ATC
paracetamol; systemic, rectal
1.7
64.0
7098
57933
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.5
63.8
548
2049
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
62.5
726
3146
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
17.8
61.5
100
51
N29
ICPC
Neurological sympt/complt other
4.1
61.5
257
578
N04BC04
ATC
ropinirole; oral
5.2
59.7
196
344
SPAT1139
SPAT
Nutrition survey
3.2
58.9
341
997
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.0
58.6
894
4330
L03AB07
ATC
interferon beta-1a; parenteral
20.3
58.1
90
40
F21
ICPC
NA
8.9
57.6
128
130
N03AX14
ATC
levetiracetam; systemic
3.5
57.1
286
751
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.2
56.6
231
508
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.2
56.1
228
500
SPAT1263
SPAT
Sampling
1.5
55.7
3516
24929
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
54.4
1343
7608
N06AB06
ATC
sertraline; oral
2.1
54.3
709
3225
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
8.0
54.2
129
147
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.0
53.7
793
3785
N86
ICPC
Multiple sclerosis
10.6
53.5
108
92
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.5
51.9
193
388
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
51.7
2621
17682
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.3
51.4
281
789
P29
ICPC
Psychological sympt/compl other
3.0
51.3
317
970
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
51.0
1327
7615
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
+∞
50.9
51
*
N05AA02
ATC
levomepromazine; systemic
2.8
50.9
354
1169
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.8
50.6
341
1105
N03AX09
ATC
lamotrigine; oral
3.2
50.3
285
821
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.5
50.3
429
1593
F02.89
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without information of additional symptoms
+∞
49.9
50
*
N99
ICPC
Neurological disease other
5.1
49.3
165
297
N06AX21
ATC
duloxetine; oral
1.9
49.1
749
3616
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
48.9
2593
17611
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
48.2
1653
20217
N30.0
ICD-10 Finland
Acute cystitis
1.7
48.1
1084
5960
N03AF02
ATC
oxcarbazepine; oral
3.0
47.9
290
873
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
47.5
983
5266
N04BX02
ATC
entacapone; oral
13.5
47.2
85
57
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.8
47.0
862
4437
N04AA02
ATC
biperiden; systemic
4.0
46.5
195
441
L03AX13
ATC
glatiramer acetate; parenteral
21.1
45.8
70
30
SPAT1262
SPAT
Handing over of treatment supplies
1.5
44.7
1723
10881
F05.8
ICD-10 Finland
Other delirium
7.3
44.7
112
139
N27
ICPC
Fear of neurological disease other
3.9
44.5
191
441
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
+∞
43.9
44
*
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
+∞
43.9
44
*
N28
ICPC
Limited function/disability (N)
3.8
43.8
195
465
SPAT1050
SPAT
Extensive neurological examination
3.2
43.3
246
710
C03CA01
ATC
furosemide; systemic
1.4
42.8
2450
16789
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
41.8
465
1966
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
4.5
41.8
154
308
N04BC05
ATC
pramipexole; oral
1.9
41.0
681
3382
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
33.0
40.8
55
15
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.9
40.7
175
405
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.9
40.5
607
2901
F0019, G301
ICD-10 Finland
NA
+∞
39.9
40
*
N05AB03
ATC
perphenazine; systemic, rectal
2.7
39.9
286
962
N05AH02
ATC
clozapine; systemic
5.5
39.8
124
206
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.3
39.6
373
1459
T90.5
ICD-10 Finland
Sequelae of intracranial injury
5.0
39.4
132
239
C10AA01
ATC
simvastatin; oral
1.4
38.5
4258
32516
N19
ICPC
Speech disorder
4.1
38.5
158
351
E86
ICD-10 Finland
Volume depletion
3.2
38.0
215
619
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
+∞
37.9
38
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.2
37.7
398
1645
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
37.6
1313
8063
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
13.8
37.2
66
43
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.1
37.2
219
649
R32
ICD-10 Finland
Unspecified urinary incontinence
2.6
37.2
280
969
F009, G309
ICD-10 Finland
NA
+∞
37.0
37
*
N05BA01
ATC
diazepam; systemic, rectal
1.6
36.5
1014
5879
F02.09
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
36.0
36
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
35.9
898
5061
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
13.4
35.7
64
43
130
Kela drug reimbursment
Malignant tumour
0.5
35.7
260
4702
N05AX12
ATC
aripiprazole; systemic
3.5
35.6
176
459
F22.0
ICD-10 Finland
Delusional disorder
4.0
35.4
147
331
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
35.0
1021
5992
K90
ICPC
Stroke/cerebrovascular accident
2.5
35.0
294
1085
F001, G301
ICD-10 Finland
NA
+∞
35.0
35
*
R1250
NOMESCO Finland
Evaluation of functional capability
3.2
34.9
197
566
N02AA05
ATC
oxycodone; systemic
1.5
34.8
1228
7543
Z75.5
ICD-10 Finland
Holiday relief care
10.2
34.7
71
63
G40
ICD-10 Finland
Epilepsy
5.3
34.7
111
191
K59.09
ICD-10 Finland
Constipation, unspecified
1.9
34.4
561
2761
G72.8
ICD-10 Finland
Other specified myopathies
3.7
34.4
157
384
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
34.3
751
4069
H02AB02
ATC
dexamethasone; systemic
0.5
34.3
313
5284
R25.1
ICD-10 Finland
Tremor, unspecified
2.4
34.1
299
1127
N04BB01
ATC
amantadine; oral
3.4
34.0
171
453
S70.0
ICD-10 Finland
Contusion of hip
2.4
33.8
291
1087
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.8
33.6
150
360
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.6
33.2
155
387
N05AN01
ATC
lithium; oral
3.3
33.1
177
491
R35
ICD-10 Finland
Polyuria
1.8
33.1
596
3037
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
+∞
33.0
33
*
N17
ICPC
Vertigo/dizziness
1.6
32.9
959
5620
R33
ICD-10 Finland
Retention of urine
1.7
32.8
709
3825
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.1
32.6
185
535
P03
ICPC
Feeling depressed
2.1
32.5
414
1853
R11
ICD-10 Finland
Nausea and vomiting
1.8
32.5
575
2911
SPAT1260
SPAT
Consultation of another employee
1.5
32.4
1518
9901
R44.1
ICD-10 Finland
Visual hallucinations
8.7
31.8
71
74
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.8
31.7
633
3333
SPAT1279
SPAT
Preparation of immediate hospitalisation
4.9
31.6
107
197
N03AX18
ATC
lacosamide; systemic
7.1
31.6
80
102
A01
ICPC
Pain general/multiple sites
1.8
31.4
600
3114
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
3.8
30.8
138
333
N05CD07
ATC
temazepam; oral
1.6
30.5
994
5981
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
30.4
564
2899
M03BX01
ATC
baclofen; systemic
3.3
30.3
161
445
N04BC09
ATC
rotigotine; transdermal
6.9
30.3
78
102
SPAT1307
SPAT
Psychosocial counselling and guidance
2.4
30.3
263
988
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.4
30.2
156
422
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.2
30.2
321
1330
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.5
30.1
146
376
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.4
30.1
155
419
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
+∞
30.0
30
*
F01.0
ICD-10 Finland
Vascular dementia of acute onset
+∞
30.0
30
*
F01.34
ICD-10 Finland
Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type
+∞
30.0
30
*
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
+∞
30.0
30
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.2
29.9
165
469
G04BD08
ATC
solifenacin; oral
1.7
29.9
630
3367
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.9
29.9
127
293
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.3
29.8
156
427
Z29
ICPC
Social problem NOS
3.7
29.4
134
328
Z01.9
ICD-10 Finland
Special examination, unspecified
1.9
29.3
470
2299
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.8
28.7
190
609
N03AF01
ATC
carbamazepine; oral, rectal
2.0
28.7
402
1870
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.1
28.6
329
1412
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.5
28.6
230
828
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.6
28.5
210
721
R63.4
ICD-10 Finland
Abnormal weight loss
2.1
28.5
335
1451
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
5.1
28.5
93
165
183
Kela drug reimbursment
Lamotrigin and topiramate
5.8
28.4
83
129
SPAT1240
SPAT
Therapeutic discussion
1.8
28.3
531
2737
SPAT1125
SPAT
Stoma care and guidance
2.9
28.1
174
536
L03AB08
ATC
interferon beta-1b; parenteral
17.6
28.1
45
23
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
28.0
698
3915
F01.80
ICD-10 Finland
Other specified vascular dementia without additional symptoms
+∞
28.0
28
*
F0009, G300
ICD-10 Finland
NA
+∞
28.0
28
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
27.9
396
1852
K59.0
ICD-10 Finland
Constipation
1.9
27.9
454
2231
J01EA01
ATC
trimethoprim; systemic
1.4
27.8
1730
11855
K91
ICPC
Cerebrovascular disease
3.1
27.6
158
462
N30.9
ICD-10 Finland
Cystitis, unspecified
2.0
27.5
390
1823
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
27.4
3125
23508
A27
ICPC
Fear of other disease NOS
2.0
27.3
378
1750
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
27.2
528
2754
SPAT1281
SPAT
Other administrative function
1.7
27.0
640
3540
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
+∞
27.0
27
*
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
+∞
27.0
27
*
164
Kela drug reimbursment
Fingolimod
26.3
26.9
38
13
J01CA08
ATC
pivmecillinam; oral
1.3
26.8
2436
17722
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.8
26.8
456
2277
S06.3
ICD-10 Finland
Focal brain injury
3.6
26.5
124
311
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
4.6
26.3
94
184
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.7
26.2
117
283
A04AA02
ATC
granisetron; systemic, transdermal
0.5
26.1
156
3021
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
+∞
26.0
26
*
F02.89*E03.9
ICD-10 Finland
Dementia in hypothyroidism, acquired
+∞
26.0
26
*
F01.23
ICD-10 Finland
Subcortical vascular dementia other additional symptoms, mainly depression
+∞
26.0
26
*
F02.80
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without additional symptoms
+∞
26.0
26
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
5.9
25.8
74
113
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.8
25.6
167
532
Z2446
NOMESCO Finland
Social worker
1.9
25.5
411
2014
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
5.8
25.4
74
115
A10AE04
ATC
insulin glargine; parenteral
1.6
25.3
733
4276
P99
ICPC
Psychological disorders other
3.1
25.2
145
426
R44.3
ICD-10 Finland
Hallucinations, unspecified
8.7
24.9
55
57
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
24.9
1643
11341
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
24.8
723
9287
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
24.5
1899
13447
353
Kela drug reimbursment
Cladribine and fingolimod
27.8
24.4
34
11
S00.0
ICD-10 Finland
Superficial injury of scalp
2.7
24.4
169
559
R1250
SPAT
NA
5.7
24.4
72
114
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.7
24.4
588
3266
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.8
24.3
71
111
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.3
24.1
231
914
F06.0
ICD-10 Finland
Organic hallucinosis
14.7
24.0
41
25
H46
ICD-10 Finland
Optic neuritis
5.5
23.9
72
117
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.4
23.9
97
2165
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
4.1
23.7
96
213
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.5
23.6
186
664
P15
ICPC
Chronic alcohol abuse
2.7
23.6
169
572
F10.24
ICD-10 Finland
Alcohol depence active use
3.6
23.6
109
272
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
7.3
23.5
58
72
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
10.3
23.5
47
41
N06AX12
ATC
bupropion; oral
2.3
23.4
222
874
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.5
23.4
85
170
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.4
23.4
85
1983
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
23.4
323
1495
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
23.4
588
3304
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
6.8
23.4
60
79
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
3.8
23.4
101
238
S22.3
ICD-10 Finland
Fracture of rib
1.7
23.3
489
2608
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
23.2
352
1691
Z28
ICPC
Limited function/disability (Z)
6.9
23.1
59
77
K08.3
ICD-10 Finland
Retained dental root
1.7
22.9
535
2945
G04BD04
ATC
oxybutynin; oral, transdermal
1.8
22.9
431
2223
N03AB02
ATC
phenytoin; systemic
3.5
22.9
109
279
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.0
22.8
285
1270
N18
ICPC
Paralysis/weakness
2.5
22.7
180
644
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.0
22.7
137
417
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.3
22.5
221
885
N88
ICPC
Epilepsy
5.5
22.5
68
111
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
3.3
22.5
118
326
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
22.2
1255
8416
B01AC04
ATC
clopidogrel; oral
1.4
22.2
1430
9810
N05CF01
ATC
zopiclone; oral
1.3
22.1
2368
17519
N05AF03
ATC
chlorprothixene; systemic
2.6
21.9
168
591
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.8
21.9
147
480
SPAT1284
SPAT
Extensive health certificate
2.4
21.8
196
751
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
5.0
21.8
71
127
SPAT1310
SPAT
Counselling related to known health issue
1.3
21.7
2566
19223
F32
ICD-10 Finland
Depressive episode
2.1
21.7
263
1158
SPAT1127
SPAT
Enema
4.2
21.6
84
180
SPAT1138
SPAT
Guidance concerning bowel function
2.9
21.4
131
403
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
4.4
21.2
79
163
H02AA02
ATC
fludrocortisone; oral
4.5
21.2
76
151
P05
ICPC
Senility, feeling/behaving old
6.8
21.1
54
71
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
8.5
21.1
47
50
G04BD07
ATC
tolterodine; oral
1.8
21.0
403
2092
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
+∞
21.0
21
*
F00, F03
ICD-10 Finland
NA
+∞
21.0
21
*
EBA30
NOMESCO Finland
Excision of root of tooth
1.7
20.8
416
2188
N05BE01
ATC
buspirone; oral
2.3
20.8
195
763
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
4.5
20.8
75
150
Y94.0
ICD-10 Finland
Accident at home
2.6
20.7
151
518
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
20.6
1289
8782
P76
ICPC
Depressive disorder
2.0
20.5
267
1209
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.0
20.4
281
1298
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.7
20.4
90
217
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
20.3
244
1071
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.4
20.3
101
269
D21
ICPC
Swallowing problem
2.8
20.2
136
444
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
20.2
1947
14163
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.2
20.1
109
309
L01BC06
ATC
capecitabine; oral
0.4
20.1
77
1756
N07BB01
ATC
disulfiram; oral
2.1
20.0
237
1033
F0011, G301
ICD-10 Finland
NA
+∞
20.0
20
*
F01.39
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without information on additional symptoms
+∞
20.0
20
*
F0014, G301
ICD-10 Finland
NA
+∞
20.0
20
*
AA1AA
NOMESCO Finland
Head X-ray examination
3.6
19.9
93
235
G04BD09
ATC
trospium; oral
2.1
19.9
232
1006
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
25.1
19.7
28
10
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
19.7
1226
8341
G91.0
ICD-10 Finland
Communicating hydrocephalus
5.1
19.7
63
111
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.5
19.6
70
139
SPAT1236
SPAT
Informing family of child’s disability
2.3
19.5
189
753
F60.9
ICD-10 Finland
Personality disorder, unspecified
4.4
19.4
72
148
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.0
19.4
257
1173
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.9
19.4
118
362
L04AA31
ATC
teriflunomide; oral
26.9
19.4
27
9
ZY010
NOMESCO Finland
Hospital outpatient
2.1
19.3
227
988
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.9
19.3
82
192
L04AA27
ATC
fingolimod; oral
22.8
19.2
28
11
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.8
19.1
83
198
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
3.5
19.1
90
230
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
12.1
19.0
35
26
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
+∞
19.0
19
*
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
4.1
18.9
76
169
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
6.3
18.9
51
73
XF606
NOMESCO Finland
Ortostatic test
3.5
18.9
90
232
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.0
18.9
111
334
WX402
NOMESCO Finland
General anaesthesia
0.7
18.9
635
7973
UKC02
NOMESCO Finland
Cystoscopy
1.3
18.8
1405
9834
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.3
18.8
185
743
R60.0
ICD-10 Finland
Localized oedema
1.4
18.8
881
5695
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
18.7
1776
12877
N05AD03
ATC
melperone; systemic
3.7
18.6
82
198
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.4
18.6
92
244
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
4.0
18.4
75
169
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
18.3
1560
11130
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.7
18.3
128
428
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
2.9
18.2
115
361
L57.0
ICD-10 Finland
Actinic keratosis
0.7
18.1
478
6282
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.0
18.1
238
1083
B03BA03
ATC
hydroxocobalamin; parenteral
1.6
18.1
435
2413
P28
ICPC
Limited function/disability (P)
4.5
18.1
65
130
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.0
18.1
109
332
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.2
18.1
192
799
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
4.1
18.1
71
155
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
+∞
18.0
18
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
17.9
485
2781
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
16.3
17.9
29
16
AA1AD
SPAT
NA
9.0
17.8
38
38
R13
ICD-10 Finland
Dysphagia
1.6
17.8
495
2856
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
3.6
17.7
82
207
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
10.9
17.7
34
28
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.7
17.6
360
1906
N05AC02
ATC
thioridazine; oral
2.5
17.6
138
494
N06AB03
ATC
fluoxetine; oral
1.4
17.5
795
5107
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
9.5
17.4
36
34
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.1
17.3
201
870
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.9
17.3
71
162
C10AA05
ATC
atorvastatin; oral
1.2
17.2
3484
27573
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
3.1
17.0
95
277
F00.12
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations
+∞
17.0
17
*
F01.8
ICD-10 Finland
Other vascular dementia
+∞
17.0
17
*
N06AA09
ATC
amitriptyline; systemic
1.4
17.0
738
4700
W06
ICD-10 Finland
Fall involving bed
3.9
16.9
71
165
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
4.0
16.8
68
153
AA1CG
SPAT
NA
4.7
16.8
58
112
SPAT1251
SPAT
Organisation of medication
1.9
16.7
258
1249
ZY000
NOMESCO Finland
Hospital inpatient
3.8
16.7
72
172
S97
ICPC
Chronic ulcer skin
1.6
16.6
444
2535
S06.2
ICD-10 Finland
Diffuse brain injury
3.5
16.6
78
200
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.5
16.5
130
468
A03FA01
ATC
metoclopramide; systemic, rectal
0.7
16.5
942
10908
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.7
16.4
337
1788
F34.1
ICD-10 Finland
Dysthymia
2.1
16.4
182
773
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.8
16.3
1727
18506
N80
ICPC
Head injury other
2.5
16.3
127
454
OAB43
SPAT
NA
0.4
16.2
59
1372
2AB04
NOMESCO Finland
NA
10.7
16.0
31
26
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.7
16.0
71
174
F01.21
ICD-10 Finland
Subcortical vascular dementia without additional symptoms, mainly paranoidism
+∞
16.0
16
*
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
+∞
16.0
16
*
F01.1
ICD-10 Finland
Multi-infarct dementia
+∞
16.0
16
*
SPAT1285
SPAT
Provision of consultation response
1.6
15.9
422
2401
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
15.8
735
4741
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.7
15.8
730
8721
Q90.9
ICD-10 Finland
Down syndrome, unspecified
152.4
15.8
17
*
N05AF05
ATC
zuclopenthixol; systemic
3.4
15.7
76
200
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.3
15.6
78
210
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
6.7
15.6
40
54
Z03
ICPC
Housing/neighbourhood problem
4.7
15.6
53
101
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.1
15.5
174
744
R51.80
ICD-10 Finland
Headache
1.4
15.5
795
5218
N06AX03
ATC
mianserin; oral
1.7
15.5
338
1826
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
3.2
15.5
82
231
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
5.3
15.5
47
79
SPAT1243
SPAT
Psychiatric/psychological examination
2.7
15.4
107
358
A10BB12
ATC
glimepiride; oral
1.5
15.4
577
3564
L75
ICPC
Fracture: femur
2.7
15.4
103
338
WX212
NOMESCO Finland
Femoral plexus blockade
2.2
15.4
151
610
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.9
15.3
214
998
Z11
ICPC
Compliance/being ill problem
4.4
15.3
56
115
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
15.3
709
4569
S09.9
ICD-10 Finland
Unspecified injury of head
3.0
15.3
91
278
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
10.4
15.3
30
26
N05BA09
ATC
clobazam; oral
5.5
15.3
45
73
A10AE05
ATC
insulin detemir; parenteral
1.6
15.2
373
2083
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
15.2
528
3211
A10BB01
ATC
glibenclamide; oral
1.8
15.1
274
1401
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
2.8
15.1
99
322
W10
ICD-10 Finland
Fall on and from stairs and steps
1.7
15.1
334
1815
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.6
15.0
411
2360
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
2.6
15.0
112
392
F02
ICD-10 Finland
Dementia in other diseases classified elsewhere
+∞
15.0
15
*
F0232, G20
ICD-10 Finland
NA
+∞
15.0
15
*
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.3
14.9
55
114
R47.0
ICD-10 Finland
Dysphasia and aphasia
3.1
14.9
85
251
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.1
14.9
174
759
EBA00
NOMESCO Finland
Extraction of tooth
1.2
14.9
2171
16515
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
7.2
14.8
36
45
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
6.4
14.8
39
55
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
6.4
14.8
39
55
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.5
14.8
69
177
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.2
14.7
2023
15282
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
6.6
14.7
38
52
E87.6
ICD-10 Finland
Hypokalaemia
1.9
14.7
231
1127
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.4
14.7
727
4744
R5110
SPAT
NA
1.9
14.6
211
999
P01
ICPC
Feeling anxious/nervous/tense
1.7
14.6
328
1789
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.4
14.6
75
1526
F31.8
ICD-10 Finland
Other bipolar affective disorders
3.3
14.5
74
203
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.2
14.5
144
583
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
14.4
934
6375
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
3.1
14.4
80
234
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
4.6
14.4
50
98
B01AA03
ATC
warfarin; systemic
1.3
14.3
1602
11803
G40.89
ICD-10 Finland
Other epilepsy
5.0
14.3
46
83
R47.1
ICD-10 Finland
Dysarthria and anarthria
3.0
14.2
82
245
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
3.9
14.2
59
137
ZXY02
NOMESCO Finland
Neuropsychologist
4.9
14.1
46
84
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.5
14.1
96
1776
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.1
14.1
161
696
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
14.0
448
2671
F02.89*A69.2
ICD-10 Finland
Dementia in Lyme disease
+∞
14.0
14
*
F00.21
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism
+∞
14.0
14
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
13.9
3452
27668
Z60.8
ICD-10 Finland
Other problems related to social environment
9.7
13.8
28
26
I95.9
ICD-10 Finland
Hypotension, unspecified
2.4
13.8
115
430
L76
ICPC
Fracture: other
1.9
13.7
201
956
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.6
13.7
101
352
IGP01
NOMESCO Finland
Psychiatric family contact
8.0
13.7
31
35
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
13.7
2566
20011
N03AX11
ATC
topiramate; oral
2.6
13.6
101
355
T08
ICPC
Weight loss
2.4
13.6
116
438
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
13.5
2114
16175
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.9
13.5
209
1016
M01AH05
ATC
etoricoxib; oral
0.8
13.4
3259
32368
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.6
13.4
326
1818
R2110
NOMESCO Finland
Giving the first information
1.6
13.4
393
2295
Z72.1
ICD-10 Finland
Alcohol use
2.9
13.3
83
262
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1.7
13.3
290
1568
D12
ICPC
Constipation
1.7
13.3
259
1358
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
5.2
13.3
41
71
SPAT1014
SPAT
Treatment of eyes
2.2
13.2
128
514
A86
ICD-10 Finland
Unspecified viral encephalitis
4.6
13.2
45
87
P72
ICPC
Schizophrenia
2.7
13.1
90
302
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.9
13.1
81
255
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
13.1
352
2015
S20
ICPC
Corn/callosity
2.0
13.0
171
783
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.0
13.0
160
714
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
3.5
13.0
61
158
4378X
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other[MORBUS CERBROVASCULARIS ALIA DEFINITA]
+∞
13.0
13
*
F01.33
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly depression
+∞
13.0
13
*
F01.84
ICD-10 Finland
Other specified vascular dementia other mixed symptoms of mixed type
+∞
13.0
13
*
E0000UV
ATC
NA
1.2
13.0
2619
20545
SPAT1255
SPAT
Intravenous administration of medicine
1.5
12.9
479
2951
SPAT1244
SPAT
Occupational therapy
2.7
12.9
88
294
U28
ICPC
Limited function/disability (U)
2.6
12.8
92
316
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.5
12.8
84
1575
Z08
ICPC
Social welfare problem
3.1
12.8
71
208
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
2.3
12.8
117
457
U13
ICPC
Bladder symptom/complaint other
1.8
12.8
224
1137
R4130
NOMESCO Finland
Speech therapy
2.0
12.8
162
730
A05
ICPC
Feeling ill
1.7
12.8
276
1489
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
3.6
12.8
57
142
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
4.1
12.7
49
107
L04AX07
ATC
dimethyl fumarate; oral
13.2
12.6
22
15
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
12.6
2096
16111
XF606
SPAT
NA
6.1
12.6
34
50
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
23.1
12.6
18
7
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.0
12.6
150
662
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
5.0
12.6
40
72
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
3.0
12.5
73
221
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
4.8
12.5
41
76
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.2
12.5
65
182
-1
ICPC
NA
2.1
12.5
140
599
Z50.1
ICD-10 Finland
Other physical therapy
1.5
12.5
386
2282
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
12.5
689
4577
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.5
12.5
430
2610
SPAT1104
SPAT
Monitoring of emergency patient
1.5
12.3
497
3118
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
2.4
12.3
108
414
188
Kela drug reimbursment
Psychosis requiring demanding treatment
3.2
12.3
63
175
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.4
12.3
564
3629
Z3229
NOMESCO Finland
Other healthcare associate professional
1.4
12.2
588
3816
C09AA05
ATC
ramipril; oral
1.2
12.2
2070
15941
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
4.3
12.1
44
91
ZXD05
NOMESCO Finland
Urgent procedure
1.2
12.1
2025
15567
S20.2
ICD-10 Finland
Contusion of thorax
1.6
12.1
288
1599
A10BA02
ATC
metformin; oral
1.2
12.1
2225
17270
HA1RA
SPAT
NA
0.3
12.0
22
696
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.4
12.0
97
357
S00.8
ICD-10 Finland
Superficial injury of other parts of head
2.4
12.0
97
357
N04BC02
ATC
pergolide; oral
11.6
12.0
22
17
G04CA02
ATC
tamsulosin; oral
1.2
12.0
1941
14870
N06AB05
ATC
paroxetine; oral
1.6
12.0
325
1865
F02.8
ICD-10 Finland
Dementia in other specified diseases classified elsewhere
+∞
12.0
12
*
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
+∞
12.0
12
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
12.0
1232
8966
Z51.88
ICD-10 Finland
Other specified medical care
2.0
11.9
152
689
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
3.4
11.9
58
155
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.3
11.9
108
421
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
11.9
1731
13112
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
3.1
11.9
64
185
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.8
11.8
967
10733
P18
ICPC
Medication abuse
6.3
11.8
31
44
S01.8
ICD-10 Finland
Open wound of other parts of head
2.5
11.7
93
340
C01DA14
ATC
isosorbide mononitrate; oral
1.3
11.7
1156
8372
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.4
11.7
531
3411
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
11.6
299
1694
TKC20
NOMESCO Finland
Catheterisation of bladder
1.4
11.6
532
3422
F32.1
ICD-10 Finland
Moderate depressive episode
1.8
11.6
193
963
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.4
11.6
94
347
E16.19
ICD-10 Finland
Other specified hypoglycaemia
5.2
11.5
35
60
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
11.5
817
5649
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
7.0
11.5
28
36
N06BA07
ATC
modafinil; oral
8.3
11.5
25
27
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
4.4
11.5
41
84
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.1
11.5
135
594
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
3.7
11.4
50
123
C07AB02
ATC
metoprolol; systemic
1.2
11.4
1590
11976
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
3.3
11.4
57
156
F61.0
ICD-10 Finland
Mixed personality disorders
2.8
11.4
71
225
N05AL01
ATC
sulpiride; systemic
2.3
11.3
107
426
F51.0
ICD-10 Finland
Nonorganic insomnia
1.4
11.3
623
4135
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
3.8
11.3
48
115
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.6
11.3
265
1465
N07XX09
ATC
[U] dimethyl fumarate; oral
16.1
11.3
18
10
S28
ICPC
Limited function/disability (S)
3.5
11.3
52
134
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
4.7
11.2
37
70
N05BA02
ATC
chlordiazepoxide; systemic
1.9
11.2
160
757
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.7
11.2
76
256
D64.9
ICD-10 Finland
Anaemia, unspecified
1.3
11.1
735
5028
G04BD11
ATC
fesoterodine; oral
1.7
11.1
240
1297
R45.1
ICD-10 Finland
Restlessness and agitation
9.9
11.1
22
20
N03AX12
ATC
gabapentin; oral
1.3
11.1
1052
7571
A46
ICD-10 Finland
Erysipelas
1.3
11.1
1029
7382
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
3.9
11.1
45
104
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
0.5
11.1
77
1411
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.1
11.0
127
553
ZXD35
NOMESCO Finland
Usual procedure
1.7
11.0
220
1162
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
8.3
11.0
24
26
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
7.7
11.0
25
29
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
3.0
11.0
63
189
S01.9
ICD-10 Finland
Open wound of head, part unspecified
2.2
11.0
108
440
F02.84
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere as other mixed symptoms of mixed type
+∞
11.0
11
*
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
11.0
11
*
F00.29
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms
+∞
11.0
11
*
F0004, G300
ICD-10 Finland
NA
+∞
11.0
11
*
F02.89*M32.8
ICD-10 Finland
Dementia in systemic lupus erythematosus
+∞
11.0
11
*
F00.23
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression
+∞
11.0
11
*
F01.14
ICD-10 Finland
Multi-infarct dementia's other mixed symptoms of mixed type
+∞
11.0
11
*
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
+∞
11.0
11
*
N06AA12
ATC
doxepin; systemic
1.5
11.0
368
2223
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
5.7
11.0
31
49
K92.0
ICD-10 Finland
Haematemesis
1.9
11.0
155
733
S80.0
ICD-10 Finland
Contusion of knee
1.5
11.0
335
1980
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.4
11.0
458
2895
T90
ICPC
Diabetes non-insulin dependent
1.2
11.0
1923
14831
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
10.5
11.0
21
18
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
10.9
644
4327
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.4
10.8
622
4159
N06AX05
ATC
trazodone; oral
2.0
10.8
137
622
S01
ICD-10 Finland
Open wound of head
2.5
10.8
84
305
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
2.1
10.8
121
522
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
4.8
10.8
35
65
Z60.9
ICD-10 Finland
Problem related to social environment, unspecified
7.5
10.8
25
30
N05BA12
ATC
alprazolam; oral
1.4
10.8
612
4086
R40.2
ICD-10 Finland
Coma, unspecified
2.9
10.8
63
193
N05AA01
ATC
chlorpromazine; systemic, rectal
2.6
10.7
79
277
M54.5
ICD-10 Finland
Low back pain
1.2
10.7
2048
15919
F31
ICD-10 Finland
Bipolar affective disorder
3.2
10.7
56
159
F32.8
ICD-10 Finland
Other depressive episodes
2.9
10.7
66
207
XA400
NOMESCO Finland
EEG
3.5
10.7
49
126
K03.66
ICD-10 Finland
Tooth plaque
1.5
10.7
408
2535
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
9.9
10.7
21
19
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
4.9
10.7
34
62
359
Kela drug reimbursment
Mirabegroni
2.9
10.6
62
190
F06.8
ICD-10 Finland
Other specified mental disorders due to brain damage and dysfunction and to physical disease
7.7
10.6
24
28
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
10.5
738
5092
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
4.3
10.5
38
79
4AA23
NOMESCO Finland
NA
22.4
10.5
15
6
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
3.7
10.5
45
110
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.9
10.4
142
663
U07
ICPC
Urine symptom/complaint other
1.4
10.4
425
2677
H04AA01
ATC
glucagon; nasal, parenteral
2.4
10.3
89
340
XKD00
NOMESCO Finland
Uroflowmetry
1.2
10.3
1419
10664
SPAT1107
SPAT
Extensive external surface anaesthesia of skin with cream or gel
5.7
10.3
29
46
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
3.0
10.3
59
178
R1260
NOMESCO Finland
Evaluation of communicative skills
2.0
10.3
124
553
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.6
10.2
172
2480
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.8
10.2
170
851
NG1AA
SPAT
NA
0.3
10.2
30
762
A04AA01
ATC
ondansetron; systemic, rectal
0.6
10.2
227
3083
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.2
10.2
38
82
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.7
10.1
191
994
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
4.3
10.1
37
78
N04BC06
ATC
cabergoline; oral (dopamine agonists)
4.4
10.1
36
74
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
4.4
10.1
36
74
IHZ08
SPAT
NA
25.1
10.1
14
5
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
4.8
10.1
33
62
Y07
ICD-10 Finland
Other maltreatment
4.5
10.1
35
70
RT150
NOMESCO Finland
NA
8.2
10.1
22
24
R4120
NOMESCO Finland
Occupational therapy
1.5
10.1
399
2493
F06.32
ICD-10 Finland
Organic depression
6.1
10.1
27
40
N06AA06
ATC
trimipramine; systemic
1.8
10.1
159
779
S22
ICPC
Nail symptom/complaint
1.4
10.1
411
2587
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
2.8
10.0
63
202
R39.1
ICD-10 Finland
Other difficulties with micturition
1.7
10.0
214
1156
F01.89
ICD-10 Finland
Other specified vascular dementia without information on additional symptoms
+∞
10.0
10
*
F01.13
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly depression
+∞
10.0
10
*
F0203, G310
ICD-10 Finland
NA
+∞
10.0
10
*
F0029, G308
ICD-10 Finland
NA
+∞
10.0
10
*
F01.22
ICD-10 Finland
Subcortical vascular dementia with additional symptoms, mainly hallucinations
+∞
10.0
10
*
F02.04
ICD-10 Finland
Dementia in Pick's disease other additional symptoms of mixed type
+∞
10.0
10
*
F02.82
ICD-10 Finland
Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations
+∞
10.0
10
*
F0200, G310
ICD-10 Finland
NA
+∞
10.0
10
*
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
3.8
9.9
41
97
U29
ICPC
Urinary symptom/complaint other
1.7
9.9
192
1011
E000001
ATC
NA
1.2
9.8
1195
8858
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
2.5
9.8
74
266
LAITO
NOMESCO Finland
NA
29.1
9.8
13
*
SPAT1232
SPAT
Communication with help of interpreter or assistant
5.8
9.8
27
42
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
5.1
9.8
30
53
A04AA55
ATC
palonosetron, combinations; systemic
0.4
9.7
36
828
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
3.7
9.7
41
99
J01MA02
ATC
ciprofloxacin; systemic
1.2
9.7
2816
22663
D17
ICPC
Incontinence of bowel
2.6
9.7
72
254
T05
ICPC
Feeding problem of adult
3.4
9.6
46
123
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.2
9.6
49
138
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
9.6
886
6354
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.1
9.5
111
486
G41.0
ICD-10 Finland
Grand mal status epilepticus
6.5
9.5
24
33
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.4
9.5
46
951
J01DB01
ATC
cefalexin; oral
1.2
9.5
6021
51451
NF3AA
NOMESCO Finland
Femur X-ray examination
2.0
9.5
126
581
A10AA02
ATC
NA
1.8
9.5
152
751
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
9.5
190
1008
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.9
9.5
138
659
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
0.3
9.5
22
617
S22.4
ICD-10 Finland
Multiple fractures of ribs
1.9
9.4
138
661
Z75.0
ICD-10 Finland
Medical services not available in home
7.8
9.4
21
24
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.6
9.4
263
1526
AA1XD
NOMESCO Finland
Other special CT of head and brain
3.6
9.4
41
102
D09
ICPC
Nausea
1.7
9.4
184
969
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.5
9.4
273
1596
N03AX16
ATC
pregabalin; oral
1.2
9.4
1591
12204
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.5
9.4
285
1684
X58
ICD-10 Finland
Exposure to other specified factors
1.3
9.4
749
5268
AA400
NOMESCO Finland
Electroconvulsive therapy
3.2
9.3
48
136
A03FA02
ATC
cisapride; oral, rectal
1.4
9.3
516
3431
G04BD10
ATC
darifenacin; oral
2.8
9.3
59
191
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.4
9.3
44
117
L03AA02
ATC
filgrastim; parenteral
0.5
9.3
59
1110
Z00.0
ICD-10 Finland
General medical examination
1.2
9.2
1255
9415
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
9.2
2611
20952
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.3
9.2
662
4586
IGV01
NOMESCO Finland
Psychiatric network contact
4.7
9.2
30
57
G40.10
ICD-10 Finland
Simple partial seizures
2.9
9.2
53
162
RS222
NOMESCO Finland
NA
2.3
9.2
81
314
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
2.5
9.1
69
247
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.2
9.1
3612
29731
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
9.1
993
7263
A99
ICPC
Disease/condition unspecnature/site
1.4
9.1
544
3664
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
6.4
9.1
23
32
Z43.5
ICD-10 Finland
Attention to cystostomy
3.2
9.1
46
129
N06AA04
ATC
clomipramine; systemic
2.0
9.1
110
492
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.7
9.0
271
3481
SPAT1165
SPAT
Peritoneal dialysis
9.5
9.0
18
17
R60.9
ICD-10 Finland
Oedema, unspecified
1.5
9.0
325
1996
S06.9
ICD-10 Finland
Intracranial injury, unspecified
3.2
9.0
46
130
F0024, G301
ICD-10 Finland
NA
+∞
9.0
9
*
F0204, G310
ICD-10 Finland
NA
+∞
9.0
9
*
F0024, G308
ICD-10 Finland
NA
+∞
9.0
9
*
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
+∞
9.0
9
*
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
+∞
9.0
9
*
F01.31
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly paranoidism
+∞
9.0
9
*
F02.00
ICD-10 Finland
Dementia in Pick's disease without additional symptoms
+∞
9.0
9
*
F002, G308
ICD-10 Finland
NA
+∞
9.0
9
*
WF002
NOMESCO Finland
Radical radiotherapy
0.7
9.0
224
2977
N05AF01
ATC
flupentixol; systemic
2.0
9.0
110
496
PJA12
NOMESCO Finland
Sentinel node biopsy
0.7
9.0
263
3391
A10BH01
ATC
sitagliptin; oral
1.3
8.8
748
5300
Z50.5
ICD-10 Finland
Speech therapy
2.3
8.8
77
299
N03AX15
ATC
zonisamide; oral
9.0
8.8
18
18
N05CD02
ATC
nitrazepam; oral
2.0
8.8
112
510
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
7.5
8.8
20
24
S82
ICPC
Naevus/mole
0.8
8.7
524
6054
N06AG02
ATC
moclobemide; oral
1.5
8.7
303
1848
R40.0
ICD-10 Finland
Somnolence
4.9
8.7
27
49
Z51.5
ICD-10 Finland
Palliative care
1.4
8.7
449
2955
RS221
NOMESCO Finland
NA
2.2
8.7
81
325
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
0.5
8.6
81
1351
N07
ICPC
Convulsion/seizure
5.3
8.6
25
42
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
3.8
8.6
35
83
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.8
8.6
1763
17933
F10.74
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol otherwise permanently impaired intelligence
12.2
8.6
15
11
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
7.2
8.6
20
25
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
8.5
496
3328
D11
ICPC
Diarrhoea
1.3
8.5
519
3507
N06BA04
ATC
methylphenidate; oral
3.6
8.5
37
93
N06AX18
ATC
reboxetine; oral
2.3
8.5
74
287
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
6.2
8.5
22
32
A23
ICPC
Risk factor NOS
1.5
8.5
295
1800
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.6
8.5
128
1889
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
1.8
8.4
134
664
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.6
8.4
227
1306
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
0.7
8.4
269
3416
R26
ICD-10 Finland
Abnormalities of gait and mobility
4.2
8.4
31
67
F07.8
ICD-10 Finland
Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
10.2
8.4
16
14
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.8
8.4
129
630
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.3
8.4
73
282
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
1.9
8.4
119
566
SPF30
NOMESCO Finland
Soling for prothesis
1.7
8.3
160
839
AA1BD
NOMESCO Finland
Extensive CT of head and brain
1.6
8.3
185
1013
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
3.7
8.3
35
86
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.6
8.2
198
1109
PA7BD
NOMESCO Finland
CT angiography of neck and brain
1.8
8.2
134
670
U05
ICPC
Urination problems other
1.4
8.2
349
2218
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
1.5
8.2
267
1605
A02BA02
ATC
ranitidine; systemic
1.2
8.2
1357
10373
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
2.4
8.2
69
262
A02BC01
ATC
omeprazole; systemic
1.2
8.2
1920
15144
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
3.0
8.2
45
135
F09
ICD-10 Finland
Unspecified organic or symptomatic mental disorder
9.6
8.1
16
15
RT250
NOMESCO Finland
NA
5.8
8.1
22
34
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.4
8.1
66
248
G23.8
ICD-10 Finland
Other specified degenerative diseases of basal ganglia
8.5
8.1
17
18
C07AB07
ATC
bisoprolol; oral
1.1
8.1
3899
32442
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.5
8.0
253
1512
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
3.3
8.0
39
107
H53.4
ICD-10 Finland
Visual field defects
1.8
8.0
143
735
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.0
8.0
98
442
RS121
NOMESCO Finland
NA
3.1
8.0
42
122
F0021, G308
ICD-10 Finland
NA
+∞
8.0
8
*
F02.89*M30.0
ICD-10 Finland
Dementia in polyarteritis nodosa
+∞
8.0
8
*
F0234, G20
ICD-10 Finland
NA
+∞
8.0
8
*
F02.29*G10
ICD-10 Finland
Dementia in Huntington's disease without information on additional symptoms
+∞
8.0
8
*
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
+∞
8.0
8
*
F00.03
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression
+∞
8.0
8
*
F0230, G20
ICD-10 Finland
NA
+∞
8.0
8
*
F00.02
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions
+∞
8.0
8
*
F000, G300
ICD-10 Finland
NA
+∞
8.0
8
*
Q90
ICD-10 Finland
Down syndrome
+∞
8.0
8
*
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
8.0
8
*
F009, F03
ICD-10 Finland
NA
+∞
8.0
8
*
F01.32
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly hallucinations
+∞
8.0
8
*
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.5
8.0
252
1507
N43
ICPC
Neurological, Other diagnostic procedure
3.1
7.9
41
118
R50.9
ICD-10 Finland
Fever, unspecified
1.3
7.9
851
6213
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
7.9
796
5768
ZXY03
NOMESCO Finland
Occupational therapist
7.3
7.9
18
22
S30.1
ICD-10 Finland
Contusion of abdominal wall
2.2
7.9
75
303
Z59.8
ICD-10 Finland
Other problems related to housing and economic circumstances
8.0
7.9
17
19
I67.2
ICD-10 Finland
Cerebral atherosclerosis
3.9
7.8
31
72
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
4.4
7.8
27
55
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.6
7.8
220
1282
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.6
7.8
206
1184
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
6.2
7.8
20
29
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.6
7.8
188
1056
AAF00
NOMESCO Finland
Ventriculostomy
2.8
7.7
46
145
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.3
7.7
472
3193
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.4
7.7
367
2382
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
3.8
7.7
31
73
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
1.6
7.7
213
1235
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
2.7
7.7
50
166
G21.8
ICD-10 Finland
Other secondary parkinsonism
5.7
7.7
21
33
H3601, E113
ICD-10 Finland
NA
1.9
7.7
112
541
A10AA01
ATC
NA
1.9
7.6
110
529
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
3.3
7.6
37
102
K88
ICPC
Postural hypotension
2.3
7.6
65
249
OAB48
SPAT
NA
0.4
7.6
33
707
Z01
ICPC
Poverty/financial problem
5.0
7.6
23
41
L03AA13
ATC
pegfilgrastim; parenteral
0.6
7.6
104
1567
F61
ICD-10 Finland
Mixed and other personality disorders
3.8
7.6
30
70
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
2.3
7.6
65
251
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
2.2
7.5
70
281
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.0
7.5
89
397
XF600
SPAT
NA
2.2
7.5
68
272
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.3
7.4
462
3134
81
HP
Angiography of the heart and coronary arteries
1.3
7.4
484
3308
-2
ICPC
NA
3.2
7.4
37
104
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
9.0
7.4
15
15
I67.4
ICD-10 Finland
Hypertensive encephalopathy
9.0
7.4
15
15
P98
ICPC
Psychosis NOS/other
3.9
7.4
29
67
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.2
7.4
805
5886
P19
ICPC
Drug abuse
3.5
7.4
32
81
C07AA05
ATC
propranolol; systemic
1.2
7.4
1030
7740
WZC30
NOMESCO Finland
Teaching
0.8
7.4
665
7315
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
2.8
7.4
44
140
R45.5
ICD-10 Finland
Hostility
11.7
7.3
13
10
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
11.7
7.3
13
10
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
2.1
7.3
79
339
A10BH05
ATC
linagliptin; oral
1.4
7.3
361
2358
R51
ICD-10 Finland
Headache
1.5
7.3
228
1360
K28
ICPC
Limited function/disability (K)
1.7
7.3
149
801
Z93.5
ICD-10 Finland
Cystostomy status
4.4
7.3
25
51
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.0
7.3
90
408
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.2
7.3
820
6018
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
2.1
7.3
83
363
H50.52
ICD-10 Finland
Exophoria
2.5
7.3
52
184
R4150
NOMESCO Finland
Neuropsychological rehabilitation
3.1
7.3
37
106
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.0
7.2
88
398
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
2.2
7.2
68
274
JN4AD
NOMESCO Finland
Body CT examination
0.7
7.2
374
4404
D07AA02
ATC
hydrocortisone; topical
1.3
7.2
678
4876
S52.5
ICD-10 Finland
Fracture of lower end of radius
1.3
7.2
623
4433
B01AC07
ATC
dipyridamole; systemic
1.5
7.1
244
1488
F07.0
ICD-10 Finland
Organic personality disorder
16.4
7.1
11
6
I95.2
ICD-10 Finland
Hypotension due to drugs
2.5
7.1
54
197
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
3.3
7.1
34
93
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
7.1
1840
14604
RS230
NOMESCO Finland
NA
3.2
7.1
35
98
T68
ICD-10 Finland
Hypothermia
3.2
7.1
35
98
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
2.0
7.1
80
351
F80.1
ICD-10 Finland
Expressive language disorder
2.7
7.1
45
147
SPAT1241
SPAT
Extensive assessment of psychosocial situation
2.8
7.1
43
139
Z27
ICPC
Fear of a social problem
4.4
7.0
24
49
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
7.0
407
2733
Z3226
NOMESCO Finland
Physiotherapist
1.2
7.0
1225
9405
F0012, G301
ICD-10 Finland
NA
+∞
7.0
7
*
F0021, G301
ICD-10 Finland
NA
+∞
7.0
7
*
F0282, G318
ICD-10 Finland
NA
+∞
7.0
7
*
F0022, G308
ICD-10 Finland
NA
+∞
7.0
7
*
F00.22
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations
+∞
7.0
7
*
F0023, G308
ICD-10 Finland
NA
+∞
7.0
7
*
F02.89*T58
ICD-10 Finland
Dementia with carbon monoxide intoxication
+∞
7.0
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
0.3
7.0
12
388
G44.2
ICD-10 Finland
Tension-type headache
1.3
7.0
694
5022
G02CB01
ATC
bromocriptine; systemic
2.6
7.0
49
171
C08CA05
ATC
nifedipine; systemic
1.3
7.0
414
2792
G40.7
ICD-10 Finland
Petit mal, unspecified, without grand mal seizures
7.9
6.9
15
17
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.5
6.9
198
1160
G72.9
ICD-10 Finland
Myopathy, unspecified
2.4
6.9
55
205
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
6.9
2124
17074
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
5.0
6.9
21
38
OAB95
SPAT
NA
0.3
6.9
11
370
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.6
6.9
158
877
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
2.0
6.9
85
387
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
3.6
6.9
29
72
S01.3
ICD-10 Finland
Open wound of ear
2.1
6.9
69
289
L03AA14
ATC
lipegfilgrastim; parenteral
0.4
6.9
30
640
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
2.6
6.8
46
158
I61
ICD-10 Finland
Intracerebral haemorrhage
5.5
6.8
19
31
R54
ICD-10 Finland
Senility
5.5
6.8
19
31
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
0.5
6.8
53
930
J01FA10
ATC
azithromycin; systemic
0.9
6.8
2945
28534
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.8
6.8
661
7214
I10
ICD-10 Finland
Essential (primary) hypertension
1.1
6.8
5054
43029
K02.1
ICD-10 Finland
Caries of dentine
1.1
6.8
3427
28474
H81.4
ICD-10 Finland
Vertigo of central origin
2.4
6.8
52
192
RF220
NOMESCO Finland
NA
1.9
6.8
98
471
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
1.9
6.8
96
458
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
9.7
6.8
13
12
2967A
ICD-9 Finland
Affective psychoses, Bipolar affective disorder, unspecified
6.8
6.8
16
21
WX111
NOMESCO Finland
Local infiltration anesthesia
0.6
6.7
111
1603
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
1.5
6.7
197
1162
C08CA01
ATC
amlodipine; oral
1.1
6.7
2963
24404
N04BC07
ATC
apomorphine; parenteral
17.9
6.7
10
5
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.0
6.6
85
392
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.3
6.6
23
48
D01AA02
ATC
natamycin; topical
1.8
6.6
114
583
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.6
6.6
150
831
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
1.7
6.6
128
679
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.5
6.6
51
894
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
1.8
6.5
113
577
A13
ICPC
Concern/fear medical treatment
1.8
6.5
108
547
G91.1
ICD-10 Finland
Obstructive hydrocephalus
3.5
6.5
28
71
P16
ICPC
Acute alcohol abuse
2.1
6.5
66
277
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
4.8
6.5
20
37
SPAT1111
SPAT
Planning of analgesia
2.1
6.5
68
289
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
1.6
6.5
160
904
N05CD08
ATC
midazolam; nasal, systemic
1.6
6.5
139
760
G25.2
ICD-10 Finland
Other specified forms of tremor
2.8
6.5
39
126
S32.8
ICD-10 Finland
Fracture of other and unspecified parts of lumbar spine and pelvis
2.3
6.5
55
213
R07.3
ICD-10 Finland
Other chest pain
1.3
6.4
607
4365
N03AX22
ATC
perampanel; oral
12.3
6.4
11
8
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
3.7
6.4
26
63
IEY01
NOMESCO Finland
Psychoeducation, individual
5.4
6.4
18
30
T93
ICPC
Lipid disorder
0.7
6.4
248
3045
G93.4
ICD-10 Finland
Encephalopathy, unspecified
4.1
6.4
23
50
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.4
6.4
267
1697
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
6.2
6.4
16
23
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.4
6.4
297
1926
R74
ICPC
Upper respiratory infection acute
0.8
6.3
937
9825
SPAT1211
SPAT
Application of soft bandage
1.3
6.3
624
4509
A10BD07
ATC
metformin and sitagliptin; systemic
1.4
6.3
306
1996
HAB40
NOMESCO Finland
Wedge excision of mammary gland
0.7
6.3
171
2232
G46.7
ICD-10 Finland
Other lacunar syndromes
14.9
6.3
10
6
B81
ICPC
Anaemia vit B12/folate deficiency
1.4
6.3
269
1716
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.4
6.3
333
2206
XX3DW
NOMESCO Finland
Time consuming IT work
0.8
6.3
506
5640
F06.30
ICD-10 Finland
Organic manic syndrome
6.7
6.3
15
20
SPAT1109
SPAT
Analgesia with portable analgesic pump
2.6
6.3
42
144
S02.11
ICD-10 Finland
Fracture of base of skull, open
3.3
6.3
29
78
G40.3
ICD-10 Finland
Generalized idiopathic epilepsy and epileptic syndromes
5.6
6.3
17
27
G31
ICD-10 Finland
Other degenerative diseases of nervous system, not elsewhere classified
20.2
6.3
9
*
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
20.2
6.3
9
*
S42.0
ICD-10 Finland
Fracture of clavicle
1.6
6.3
139
767
Z3231
NOMESCO Finland
Registered nurse
1.2
6.3
1887
15125
WYA30
SPAT
NA
3.0
6.3
34
103
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
3.2
6.3
31
88
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
6.3
83
1259
F39
ICD-10 Finland
Unspecified mood [affective] disorder
2.4
6.3
51
194
C10AA04
ATC
fluvastatin; oral
1.2
6.3
697
5113
M79.6
ICD-10 Finland
Pain in limb
1.1
6.3
2432
19844
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
1.9
6.2
80
371
DJA10
NOMESCO Finland
Biopsy of septum of nose
5.2
6.2
18
31
R63.1
ICD-10 Finland
Polydipsia
4.2
6.2
22
47
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.2
6.2
1361
10647
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
4.4
6.2
21
43
I49.3
ICD-10 Finland
Ventricular premature depolarization
0.7
6.2
266
3217
I68.0*E85.9
ICD-10 Finland
Cerebral amyloid angiopathy
6.0
6.2
16
24
34510
ICD-8 Finland
Epilepsy, """"Grand mal""""
3.8
6.2
24
56
N32.0
ICD-10 Finland
Bladder-neck obstruction
2.0
6.2
75
339
J01DA01
ATC
[U] cefalexin; systemic
1.1
6.2
4153
35038
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
1.4
6.2
274
1762
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
1.7
6.2
126
680
A08
ICPC
Swelling
1.4
6.1
284
1838
Q90.0
ICD-10 Finland
Trisomy 21, meiotic nondisjunction
62.8
6.1
7
*
30041
ICD-8 Finland
Neuroses, Depressiva
1.9
6.1
81
381
N05AB01
ATC
dixyrazine; systemic
2.0
6.1
75
344
RS122
NOMESCO Finland
NA
4.7
6.1
19
36
A02BC03
ATC
lansoprazole; oral
1.1
6.1
2000
16134
Y94.1
ICD-10 Finland
Accident in connection with service housing
9.0
6.0
12
12
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
6.0
1807
14475
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
2.9
6.0
35
110
H25.1
ICD-10 Finland
Senile nuclear cataract
1.1
6.0
2128
17246
H53.2
ICD-10 Finland
Diplopia
1.5
6.0
183
1092
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
4.0
6.0
22
49
S82.0
ICD-10 Finland
Fracture of patella
1.8
6.0
98
496

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
982
1668
4.22
316.04
1.2
1.4
e6/l
12.1
23.0
0.94
776
1302
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
981
1668
4.21
315.31
1.3
1.4
e6/l
588.5
2369.5
0.78
804
1377
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
987
1704
4.15
311.15
1.2
1.3
mmol/l
3.9
3.8
0.36
924
1594
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
10660
52690
1.85
307.65
2.4
2.1
pmol/l
91.4
93.4
3.86
5721
26959
(3021960) Folate [Moles/volume] in Serum or Plasma
7181
31418
1.90
307.65
1.7
1.6
nmol/l
19.9
20.5
1.71
6135
26303
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
6396
26256
2.00
307.65
1.8
1.7
pmol/l
4863320.8
31361496.9
8.00
5141
20653
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
1117
1958
4.11
307.65
1.2
1.3
mg/l
509.1
579.8
1.55
1021
1869
(3009466) Valproate [Moles/volume] in Serum or Plasma
743
956
5.53
307.65
4.0
4.0
umol/l
338.0
342.4
0.28
607
803
(3019309) Folate [Moles/volume] in Red Blood Cells
8221
26006
3.01
307.65
1.9
1.8
nmol/l
1177.0
1151.3
1.52
6159
19013
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
965
458
15.22
307.65
1.0
1.0
ng/l
594.7
800.5
15.24
685
274
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
966
460
15.17
307.65
1.0
1.0
ng/l
50.8
36.8
9.47
697
278
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
953
462
14.89
307.65
1.0
1.0
ng/l
373.2
303.2
2.75
698
288
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5473
23798
1.81
258.42
2.8
3.2
mmol/l
2.5
2.5
11.11
4714
20589
(3015377) Calcium [Moles/volume] in Serum or Plasma
8297
40662
1.70
257.29
2.5
3.4
mmol/l
2.4
2.4
0.36
6875
34302
(3044290) Cell count panel - Cerebral spinal fluid
865
1573
3.92
254.26
1.2
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
8126
40478
1.65
228.35
4.0
3.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
11380
62818
1.58
198.24
5.4
6.8
mmol/l
1.2
1.2
30.69
9246
52490
(3023368) Bacteria identified in Blood by Culture
7295
36902
1.57
179.42
4.1
4.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
9876
53594
1.54
176.46
3.7
4.7
g/l
34.4
34.3
0.99
8801
49245
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
4790
22141
1.65
168.73
1.9
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
13171
76613
1.55
166.28
6.4
5.2
e6/l
2925.2
1164.6
2.52
319
1187
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
8368
44645
1.50
154.19
2.2
2.2
nmol/l
77.8
80.8
14.89
7034
38464
(3023410) Appearance of Cerebral spinal fluid
444
708
4.40
153.58
1.3
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
10266
57190
1.49
152.57
4.9
6.1
mmol/l
1.2
1.2
15.57
9023
51119
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
8884
48312
1.48
146.47
4.8
4.3
ng/l
82.0
80.6
0.02
7255
38150
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1987
7510
1.92
136.64
1.6
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4807
45096
0.65
133.19
2.1
2.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
7122
37659
1.47
130.33
2.4
2.1
u/l
261.0
213.3
3.99
6649
34893
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2694
28340
0.60
121.77
1.5
1.6
mmol/l
1.3
1.3
0.24
2213
23046
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
3269
15292
1.57
102.45
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
3269
15394
1.56
99.16
1.8
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
396
845
3.28
91.99
1.2
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
6820
37558
1.38
90.00
3.2
4.2
ph
7.4
7.4
0.93
1256
7073
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
6070
33285
1.37
79.73
2.3
2.3
mg/l
3.1
3.1
0.26
4920
28126
(3019150) Specific gravity of Urine by Refractometry
4488
23731
1.39
72.13
5.5
4.7
kg/l
1.0
1.0
1.37
765
3847
(3037467) Urinalysis macro (dipstick) panel - Urine
12547
77649
1.31
65.65
5.5
4.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
1032
3981
1.83
64.97
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
7018
40245
1.31
64.53
5.5
4.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
11372
69616
1.29
63.35
4.8
4.8
mmol/l
7.1
6.9
11.67
10754
65525
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
13074
98171
0.76
63.06
4.3
4.9
mmol/l
1.4
1.4
1.36
11321
87057
(3006270) Folate [Moles/volume] in Blood
380
988
2.68
62.91
1.3
1.2
nmol/l
309.8
311.3
0.05
296
737
(4035726)
938
11099
0.56
61.94
1.3
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
7715
45119
1.29
59.88
2.5
2.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1421
15002
0.63
59.16
1.2
1.2
u/ml
14.5
16.1
0.28
422
4911
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
273
633
3.00
55.54
2.4
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
4596
39067
0.75
55.46
2.9
3.3
mg/l
471.6
396.4
0.47
2975
24748
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1853
8688
1.52
54.76
1.8
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
13312
99195
0.78
54.74
4.3
4.9
mmol/l
4.3
4.4
23.33
11607
88778
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
12274
76611
1.27
53.70
3.9
4.1
pmol/l
15.3
15.2
2.66
10671
67431
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
12673
94908
0.78
53.32
3.8
4.4
mmol/l
1.2
1.3
5.16
10843
83234
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1585
16001
0.66
53.02
1.2
1.3
iu/ml
49.9
41.8
0.91
468
4835
(3014271) Vancomycin [Susceptibility]
328
875
2.61
51.73
3.2
3.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
5269
29748
1.30
51.41
5.3
4.6
estimate
0.0
0.0
1.91
1473
9652
(3035350) Ketones [Presence] in Urine by Test strip
8914
53784
1.26
50.55
4.9
4.1
estimate
0.0
0.0
0.50
1612
10135
(3009508) Creatinine [Moles/volume] in Urine
4685
39314
0.77
49.95
2.8
3.2
mmol/l
7.0
6.9
0.84
3673
32063
(3002256) Pathology report gross observation
1590
15746
0.67
47.84
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
843
9613
0.59
47.73
1.3
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
8969
54536
1.24
45.67
5.0
4.2
estimate
0.0
0.0
1.34
1586
10007
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
14576
93658
1.27
44.97
5.0
5.0
mu/l
2.0
2.1
2.66
12911
82931
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1951
9597
1.45
44.95
1.6
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
5012
41274
0.78
44.57
3.5
4.0
mg/mmol
12.1
9.6
1.78
3166
25814
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
175
353
3.44
44.47
1.2
1.2
%
35.6
61.2
—
8
45
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1443
6735
1.51
43.15
1.8
1.6
%
1.7
1.6
0.48
1166
5469
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
13904
102249
0.79
42.98
4.9
5.6
mmol/l
2.4
2.5
28.60
12122
91183
(1761868) Lipid panel - Serum or Plasma
2980
26119
0.75
42.33
3.5
3.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
8824
53857
1.23
42.02
6.5
5.6
estimate
0.0
0.0
0.80
1590
10195
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
873
9420
0.62
38.96
1.5
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
3602
19950
1.30
38.75
30.0
31.6
inr
1.6
1.5
1.36
414
2681
(3026782) Osmolality of Urine
4517
25849
1.27
37.26
3.2
2.9
mosm/kgh2o
558.2
543.5
4.89
3851
21837
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
1217
5675
1.51
36.39
2.0
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
1139
5246
1.53
36.08
1.9
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
175
3084
0.39
35.82
1.4
1.8
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
150
320
3.25
35.12
3.1
2.6
umol/l
28.6
29.6
0.41
107
239
(3003694) ABO and Rh group [Type] in Blood
3037
25943
0.77
34.42
1.2
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
298
928
2.23
33.84
1.3
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
2027
10538
1.36
33.35
3.0
3.1
kpa
4.3
4.4
3.13
1946
10161
(3037522) Nuclear Ab [Titer] in Serum
1285
12439
0.69
33.28
1.3
1.3
titre
510.5
526.8
0.13
290
2885
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
2369
12650
1.33
32.62
2.5
2.5
ug/l
5.3
6.6
3.68
1737
10890
(3023183) Ammonium ion [Moles/volume] in Plasma
593
2383
1.74
32.44
1.9
2.2
umol/l
28.6
33.6
5.16
454
1927
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
15691
102885
1.24
31.56
20.9
18.3
mg/l
29.5
27.3
11.22
13587
84836
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
930
9474
0.66
31.45
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
73
1852
0.27
31.11
1.2
1.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
237
693
2.37
31.10
1.2
1.2
mmol/l
2.1
2.3
1.09
216
636
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
85
1972
0.29
30.79
1.4
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
994
4602
1.52
30.67
2.1
2.2
ug/l
816.4
542.5
0.64
927
4362
(3000492) Spirometry study
782
8153
0.65
29.54
1.5
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
2022
10772
1.33
28.04
3.3
4.0
mmol/l
1.2
1.2
0.43
1684
9316
(4010399)
842
8533
0.67
27.61
1.5
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
218
650
2.33
27.46
1.1
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
6346
38682
1.19
26.38
3.8
3.5
e6/l
106.8
118.8
0.21
5059
30032
(40761535) Cells panel - Urine sediment
1985
10637
1.32
26.33
3.8
3.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1707
15231
0.75
26.00
2.7
4.0
ug/l
17.2
25.7
0.96
1405
12733
(3022145) Colonoscopy Study observation
1354
12486
0.73
25.79
1.3
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
4621
27401
1.21
25.71
3.0
2.7
e6/l
5.4
4.9
2.09
4053
23893
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
1275
6407
1.40
25.57
4.1
4.3
%
45.9
46.6
0.49
1261
6326
(3041096) Erythrocytes [Presence] in Urine by Automated
4558
27026
1.21
25.30
4.8
4.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
13291
96691
0.84
25.11
19.4
17.8
ml/min/173m2
69.4
70.4
5.97
10910
80516
(3019832) Treponema pallidum Ab [Presence] in Serum
561
2382
1.64
25.10
1.2
1.4
—
—
—
0
0
(3019225) pH of Specimen
2396
13283
1.28
24.48
4.1
4.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
7046
43549
1.18
24.39
4.3
4.0
e6/l
152.4
123.9
0.98
5298
31863
(3012544) pH of Venous blood
2393
13332
1.27
23.42
3.2
3.7
ph
7.4
7.4
0.17
11
70
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
5989
36622
1.18
23.25
2.4
2.6
u/l
57.7
60.3
2.02
5453
33452
(40768797) Stomach Pathology biopsy report
1844
16038
0.77
22.96
1.2
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
3879
31074
0.83
22.70
2.5
3.0
umol/l
8266.2
6454.4
1.17
3070
25982
(3021447) Carbon dioxide [Partial pressure] in Venous blood
2314
12886
1.27
22.68
3.2
3.7
kpa
5.8
5.8
0.03
2234
12492
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
107
245
3.02
22.53
1.3
1.2
%
48.3
20.8
—
7
41
(3002032) Base excess in Venous blood by calculation
2308
12867
1.27
22.40
3.2
3.7
mmol/l
2.1
1.9
1.08
1889
10399
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
142
384
2.56
22.10
2.6
2.1
umol/l
62.9
56.6
1.19
97
289
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
79
155
3.52
21.15
11.7
11.4
nmol/l
674.1
832.5
1.97
74
146
(3013139) Helicobacter pylori Ag [Presence] in Stool
693
6923
0.68
20.98
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
2699
15499
1.23
19.99
10.1
8.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1612
8706
1.30
19.99
5.3
6.8
mmol/l
24.6
24.6
0.01
1527
8110
(3027273) Bicarbonate [Moles/volume] in Venous blood
1325
6962
1.33
19.99
3.3
3.5
mmol/l
25.3
25.1
1.17
1288
6766
(3032080) INR in Blood by Coagulation assay
8577
54385
1.15
19.95
11.4
11.4
inr
1.3
1.4
1.39
2288
14616
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
656
3063
1.49
19.48
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
656
3063
1.49
19.48
1.4
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
90
204
3.05
19.34
16.7
11.3
mmol/l
0.7
0.6
0.96
82
185
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
1122
5796
1.35
18.93
3.9
5.0
%
1.6
1.6
0.58
1072
5445
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
13232
86722
1.16
18.71
6.0
7.9
u/l
81.0
81.8
0.66
12084
81158
(3021589) Normoblasts [#/volume] in Blood
6267
47665
0.86
18.58
10.9
10.8
e9/l
0.0
0.0
1.24
5167
38658
(4027681)
113
301
2.60
18.21
1.2
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
1211
6379
1.33
17.94
2.6
2.6
%
1.1
1.2
0.26
1205
6343
(3004119) Hemoglobin [Mass/volume] in Venous blood
1522
8290
1.29
17.64
3.2
3.3
g/l
127.0
126.1
0.88
1487
8073
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
444
4680
0.65
17.59
2.9
4.0
u/ml
128.6
86.2
0.60
420
4486
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
7106
53429
0.87
17.55
4.1
4.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
1188
6261
1.33
17.53
2.6
2.6
%
0.7
0.7
2.07
1136
6009
(3007930) Methemoglobin/Hemoglobin.total in Blood
1100
5734
1.34
17.49
3.9
5.0
%
0.9
0.9
1.08
1055
5376
(3022621) pH of Urine by Test strip
1437
7816
1.29
16.83
4.0
3.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
4394
26759
1.17
16.82
4.7
4.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
271
3170
0.58
16.78
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
447
1991
1.56
16.55
2.7
2.5
—
—
—
0
0
(4094501)
225
2750
0.56
16.42
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
101
272
2.57
15.99
1.3
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
143
453
2.19
15.87
1.1
1.1
mg/l
35.9
46.3
3.22
115
389
(3028707) Methadone [Presence] in Urine by Screen method
93
241
2.67
15.87
2.0
1.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
136
423
2.23
15.78
1.1
1.1
mg/l
264.1
327.0
3.22
114
372
(3038515) Glucose [Moles/volume] in Venous blood
660
3222
1.43
15.63
4.0
3.7
mmol/l
8.1
7.6
2.83
647
3155
(3020191) Ethanol [Moles/volume] in Serum or Plasma
163
555
2.03
15.08
1.4
1.3
promille
1.0
1.1
0.60
129
410
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
155
519
2.07
14.99
1.3
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
684
3388
1.41
14.95
3.9
3.5
mmol/l
1.7
1.6
1.08
670
3313
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
236
2767
0.58
14.79
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
511
5058
0.69
14.73
1.9
3.2
u/ml
1160.7
2225.4
0.49
407
4325
(36304419) Bacteria [Presence] in Urine
5431
33891
1.14
14.52
3.7
3.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
38
59
4.45
13.87
2.4
2.0
umol/l
22.1
17.6
1.14
38
59
(3040151) Glucose [Moles/volume] in Capillary blood
362
1604
1.57
13.79
6.0
12.7
mmol/l
8.0
7.3
1.90
280
1329
(3030467) Casts [#/volume] in Urine by Automated count
5688
35706
1.14
13.74
3.7
3.4
e6/l
0.5
0.5
1.07
4509
27269
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
54
1038
0.36
13.70
1.2
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
190
2301
0.57
13.49
1.2
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
12183
80117
1.13
13.49
4.0
4.4
mm/h
15.2
15.2
0.15
10860
72749
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
237
2698
0.60
13.26
2.2
2.2
%
203.3
209.5
0.54
216
2554
(3007164) IgA [Mass/volume] in Serum or Plasma
2090
16959
0.83
13.13
1.4
1.5
g/l
2.9
2.7
1.51
1072
9211
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
255
2832
0.62
12.88
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
148
517
1.98
12.85
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
124
1678
0.51
12.83
1.2
1.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
62
145
2.95
12.80
1.1
1.3
%
24.0
52.1
3.42
21
67
(3005322) IgE [Units/volume] in Serum or Plasma
495
4791
0.71
12.60
1.3
1.3
u/ml
245.5
249.5
0.04
440
4351
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
318
3341
0.65
12.50
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
943
8290
0.77
12.48
1.4
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
163
2013
0.55
12.46
2.6
4.0
iu/ml
552.2
1853.7
0.86
16
307
(40768443) Skin Pathology biopsy report
593
5551
0.73
12.29
1.2
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
264
2867
0.63
12.11
1.9
2.0
%
93.5
87.2
4.59
241
2703
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
280
2993
0.64
11.96
1.9
3.0
u/ml
555.3
713.4
0.15
241
2724
(4034850)
656
3352
1.36
11.96
13.7
12.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
785
4137
1.32
11.65
3.5
4.2
mmol/l
3.9
3.9
0.12
708
3882
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
3354
25970
0.87
11.56
3.0
3.5
ug/l
0.8
0.8
1.24
2410
19265
(3024891) Influenza virus A+B Ag [Presence] in Specimen
490
2399
1.42
11.53
1.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
122
414
2.04
11.52
1.1
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
16177
108628
1.14
11.36
25.0
22.0
mmol/l
139.6
139.5
7.81
15651
105768
(3002179) Metamyelocytes/100 leukocytes in Blood
1072
9166
0.80
11.24
3.1
3.7
%
0.7
0.6
0.31
231
2260
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
141
509
1.92
11.21
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
758
3998
1.32
11.19
5.7
4.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
158
1901
0.57
11.04
1.1
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
766
4061
1.31
10.91
4.4
6.0
mmol/l
1.4
1.3
0.69
698
3601
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
217
2404
0.62
10.91
1.2
1.2
u/ml
8.6
5.2
0.28
36
410
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
6887
44188
1.11
10.89
3.1
3.3
ng/l
2069.5
1879.1
2.35
5811
38665
(3023103) Potassium [Moles/volume] in Serum or Plasma
16185
108754
1.14
10.88
25.1
22.2
mmol/l
4.0
4.0
1.66
15632
105733
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1575
9093
1.21
10.79
1.8
2.2
nmol/l
389.0
382.0
0.70
1365
8250
(40768795) Lymph node Pathology biopsy report
80
1179
0.47
10.73
1.1
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1211
10165
0.81
10.70
3.2
3.8
%
1.0
0.9
0.21
345
3172
(3021879) Hepatitis B virus core Ab [Presence] in Serum
546
5065
0.74
10.70
1.3
1.3
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
65
173
2.60
10.69
2.2
2.3
nmol/l
137.6
131.7
0.19
52
149
(3018405) Lactate [Moles/volume] in Arterial blood
896
4868
1.28
10.62
3.3
3.9
mmol/l
1.4
1.4
0.30
879
4776
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
302
3090
0.67
10.48
2.4
2.1
g/l
3.6
3.7
0.64
281
2933
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
217
2379
0.62
10.45
1.2
1.2
u/ml
12.0
4.4
0.37
24
270
(3019060) Gas panel - Arterial blood
1641
9543
1.20
10.42
3.7
4.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
677
6061
0.76
10.34
1.7
1.9
g/l
1.6
1.4
0.63
576
5376
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1240
7026
1.23
10.23
3.1
2.9
e6/l
0.4
0.3
0.76
1220
6907
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
238
2540
0.64
10.16
1.2
1.2
u/ml
31.2
40.4
0.22
18
143
(3021440) Promyelocytes/100 leukocytes in Blood
1149
9641
0.81
10.12
3.3
3.9
%
0.1
0.1
0.14
317
2948
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1107
9319
0.81
10.06
3.0
2.9
ml/min/173m2
59.2
57.5
0.98
481
4167
(3001122) Ferritin [Mass/volume] in Serum or Plasma
6806
43782
1.11
10.02
2.8
2.9
ug/l
146.3
161.7
4.98
5876
39276
(3027945) Reticulocytes/100 erythrocytes in Blood
2783
16957
1.15
10.00
2.0
2.4
%
1.7
1.8
0.98
2277
14848
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
60
159
2.61
9.98
2.2
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
13729
97714
0.90
9.79
6.8
6.9
mmol/mol
42.3
41.0
32.66
12078
87955
(3045142) Bone marrow Pathology biopsy report
123
1531
0.55
9.78
1.3
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
4116
25798
1.13
9.58
4.4
4.2
ng/l
213.5
457.3
6.16
3637
22553
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
125
1538
0.56
9.55
1.8
2.1
u/ml
835.1
1777.0
—
9
107
(3017446) Testosterone [Moles/volume] in Serum or Plasma
788
6848
0.79
9.52
2.0
2.1
nmol/l
10.9
11.0
0.11
650
5750
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
59
159
2.56
9.51
2.2
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
1066
8950
0.81
9.44
3.3
3.9
%
0.5
0.3
0.22
265
2489
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
186
2055
0.62
9.32
1.2
1.2
u/ml
1.8
6.5
1.96
18
167
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
2199
13235
1.16
9.29
4.8
3.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
516
2651
1.35
9.18
4.0
3.8
mg/l
31.4
29.5
0.49
365
1709
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
270
2743
0.67
9.09
1.6
1.8
mg/l
12.5
12.3
0.13
236
2493
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
167
1879
0.61
9.06
1.5
1.6
mg/l
3.3
3.5
0.10
129
1381
(4281824)
91
1209
0.52
9.04
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
9004
58960
1.10
8.87
3.2
3.1
u/l
53.0
57.4
3.30
7947
52932
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
14258
101125
0.90
8.85
5.0
5.4
mmol/l
6.2
6.1
11.10
12318
89211
(3009343) pH of Capillary blood
1475
8629
1.19
8.78
3.2
3.8
ph
7.4
7.4
0.04
186
1153
(3000494) Fungus identified in Specimen by Culture
1578
12687
0.85
8.76
1.4
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
710
3843
1.28
8.73
3.6
3.1
nmol/l
0.8
0.8
0.10
538
3003
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1428
8336
1.20
8.70
3.2
3.8
mmol/l
2.0
2.0
0.31
1023
6218
(3009445) Proteinase 3 Ab [Units/volume] in Serum
620
5480
0.77
8.62
1.3
1.5
u/ml
35.1
17.6
0.65
11
121
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
473
4332
0.75
8.57
1.4
1.7
u/l
37.4
38.2
0.32
384
3633
(3008898) HLA-B27 [Presence]
150
1707
0.60
8.55
1.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
64
937
0.47
8.54
2.0
1.3
iu/ml
22.2
29.1
—
6
39
(3017143) Hepatitis C virus Ab [Presence] in Serum
930
7830
0.81
8.48
1.4
1.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
379
3582
0.72
8.47
1.6
1.4
iu/ml
23.9
16.3
—
9
86
(3039443) Prostate specific Ag panel - Serum or Plasma
96
1228
0.54
8.46
1.5
1.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
560
2950
1.32
8.44
4.6
6.7
mmol/l
105.1
104.8
0.65
519
2641
(3039000) Anion gap in Blood
560
2950
1.32
8.44
4.6
6.7
mmol/l
11.3
11.3
0.13
519
2641
(3018677) aPTT in Platelet poor plasma by Coagulation assay
3254
20248
1.13
8.42
1.8
1.9
s
29.7
30.2
4.52
3137
19653
(3008116) Ketones [Moles/volume] in Urine by Test strip
67
204
2.27
8.39
1.5
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1487
8741
1.19
8.38
3.2
3.8
kpa
5.2
5.1
2.32
1306
8058
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
3324
20719
1.13
8.36
3.4
3.2
e6/l
3.1
2.4
2.28
1923
11635
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
1059
6035
1.22
8.31
1.8
1.9
ug/l
3.0
2.2
0.80
826
5273
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
75
241
2.15
8.28
1.1
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
44
112
2.71
7.97
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
78
259
2.08
7.95
1.1
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
377
3527
0.73
7.91
1.2
1.2
u/ml
0.4
1.0
2.24
41
352
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
102
375
1.88
7.83
1.5
1.7
umol/l
106.8
99.6
0.14
57
214
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
164
1787
0.63
7.81
1.4
1.5
pmol/l
317.1
232.3
0.34
156
1733
(40761511) CBC panel - Blood by Automated count
15429
103874
1.11
7.79
20.2
17.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
100
366
1.89
7.79
1.9
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
553
2943
1.30
7.78
1.2
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
78
262
2.06
7.73
1.1
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
912
7617
0.82
7.70
2.4
2.8
g/l
10.6
10.7
0.07
797
6918
(3003181) Sodium [Moles/volume] in Urine
494
2593
1.32
7.68
1.4
1.3
mmol/l
65.0
61.2
1.43
397
2092
(42529406) Shigella sp [Presence] in Stool by Culture
559
2985
1.30
7.68
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
557
2973
1.30
7.67
1.2
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
8810
63665
0.92
7.65
6.7
8.8
e9/l
4.7
4.4
21.21
7600
54819
(3028271) Lactate [Moles/volume] in Capillary blood
427
2196
1.35
7.63
1.9
1.9
mmol/l
1.9
1.7
2.63
419
2143
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
207
931
1.54
7.62
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
210
950
1.53
7.54
1.3
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
156
1703
0.63
7.51
2.9
3.5
u/ml
29.8
44.5
1.64
147
1653
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
537
4745
0.77
7.50
1.1
1.2
iu/ml
92.6
126.4
1.30
176
1526
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
307
2938
0.72
7.46
1.8
1.5
g/l
1.1
1.2
0.57
290
2754
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
62
871
0.49
7.41
1.2
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
124
1424
0.60
7.41
1.2
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
2256
13826
1.14
7.36
1.8
1.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
87
310
1.94
7.35
2.6
2.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
251
2478
0.69
7.33
1.4
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
375
3467
0.74
7.31
1.7
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
1178
6881
1.19
7.16
4.8
4.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
139
1537
0.62
7.11
1.2
1.3
nmol/l
0.3
0.3
0.11
12
121
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
156
1678
0.64
7.06
1.2
1.2
u/ml
30.5
46.1
0.54
14
186
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
36
603
0.41
6.92
1.8
1.3
u/ml
1.2
1.3
0.09
26
333
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
139
1527
0.63
6.92
1.2
1.3
nmol/l
0.6
1.8
0.89
124
1454
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
302
2860
0.72
6.91
1.8
1.4
g/l
0.2
0.2
0.48
284
2669
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
21
36
4.03
6.91
1.6
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3908
29185
0.90
6.83
2.3
2.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
925
5310
1.21
6.80
1.3
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
174
1810
0.66
6.73
1.9
2.4
—
—
—
0
0
(3010421) pH of Blood
648
3587
1.25
6.72
3.8
4.2
ph
7.4
7.4
0.99
551
3062
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2159
16641
0.88
6.64
2.8
3.9
u/l
246.8
249.7
0.36
1934
15647
(3022806) Fractional oxyhemoglobin in Capillary blood
345
1757
1.36
6.63
1.9
1.9
%
88.9
89.0
0.13
340
1733
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
613
5250
0.80
6.61
2.5
2.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
477
4202
0.78
6.55
1.6
1.6
titre
186.7
242.1
0.44
30
197
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
106
1224
0.60
6.53
1.0
1.1
g/l
1.6
1.6
0.78
95
1079
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
154
1631
0.65
6.52
1.5
1.7
nmol/l
52.8
47.8
1.35
144
1537
(21494434) Karyotype in Bone marrow
114
1291
0.61
6.49
1.1
1.1
—
—
—
0
0
(3036603) Volume of Urine
63
840
0.52
6.48
1.4
1.6
ml
1693.1
1877.3
0.50
26
232
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
197
1984
0.68
6.48
1.4
1.8
ug/l
17.2
24.6
3.92
189
1930
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
9315
61605
1.08
6.40
4.3
6.2
umol/l
12.1
12.3
0.32
8602
58414
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
50
152
2.27
6.39
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
313
2904
0.74
6.31
2.1
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
571
3139
1.26
6.31
3.9
4.3
mmol/l
2.5
2.7
1.56
398
2172
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
74
264
1.94
6.30
1.1
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
126
1383
0.63
6.30
1.2
1.3
u/ml
108.2
123.9
1.13
37
310
(3013290) Carbon dioxide [Partial pressure] in Blood
571
3141
1.26
6.27
3.9
4.3
kpa
5.0
5.0
0.29
551
3060
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
100
394
1.75
6.25
1.9
2.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
100
394
1.75
6.25
1.9
2.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
249
1219
1.41
6.10
1.4
1.3
mosm/kgh2o
275.7
275.3
0.11
168
902
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
164
1688
0.67
6.07
1.1
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
196
918
1.48
6.06
1.1
1.1
mmol/l
32.7
35.3
0.93
156
766
(4198724)
35
92
2.63
6.05
1.6
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
134
577
1.61
6.04
1.7
1.4
umol/l
15.5
14.7
0.41
126
533
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
79
293
1.86
6.02
1.6
1.2
nmol/l
98.8
134.8
1.47
56
212
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1681
10252
1.14
5.90
2.9
3.7
ng/l
90.0
99.2
3.97
1310
8583
(3027315) Oxygen [Partial pressure] in Blood
570
3159
1.25
5.90
3.9
4.4
kpa
8.1
8.4
2.46
549
3078
(3020891) Body temperature
938
5472
1.19
5.84
4.2
4.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
2153
13351
1.13
5.82
3.1
3.1
ng/l
243.6
261.3
0.80
1960
12322
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
72
264
1.88
5.70
1.1
1.1
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
93
1069
0.60
5.69
1.7
1.8
mg/l
4.4
4.6
0.12
83
1004
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
49
156
2.17
5.66
1.1
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
100
1126
0.61
5.63
1.3
1.2
u/ml
24.2
54.7
—
8
87
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
157
1602
0.67
5.60
1.2
1.3
—
—
—
0
0
(3036489) Thrombin time
443
3856
0.79
5.57
1.7
1.8
s
21.2
22.2
1.89
398
3474
(3003396) Base excess in Arterial blood by calculation
2555
16043
1.11
5.54
4.6
6.4
mmol/l
1.4
1.1
3.03
1935
12567
(3042631) Mycobacterium sp identified in Specimen
231
2194
0.72
5.48
2.2
2.7
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
13
18
4.98
5.44
8.3
8.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
67
244
1.90
5.43
1.4
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
94
1064
0.61
5.43
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
142
1468
0.66
5.43
1.5
1.6
g/l
0.8
0.9
0.49
109
1087
(3022096) Basophils/100 leukocytes in Blood
6930
50111
0.93
5.42
5.1
5.9
%
0.6
0.6
7.54
6261
46169
(40768441) Liver Pathology biopsy report
53
702
0.52
5.42
1.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
3487
22276
1.10
5.34
3.2
3.0
e6/l
1.5
1.4
0.54
2060
13100
(1002224) Polysomnography panel
210
2016
0.72
5.34
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
356
1889
1.31
5.27
1.6
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
213
0.26
5.21
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
105
443
1.64
5.20
1.9
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
54
701
0.53
5.19
1.2
1.1
u/ml
0.3
1.4
2.40
15
269
(3006504) Eosinophils/100 leukocytes in Blood
7129
51439
0.93
5.19
5.1
5.9
%
2.7
2.8
2.02
6432
47337
(3006315) Basophils [#/volume] in Blood
7615
54794
0.93
5.09
4.8
5.6
e9/l
0.0
0.0
2.44
6463
46193
(3019069) Monocytes/100 leukocytes in Blood
7171
51705
0.93
5.08
5.5
6.2
%
8.8
9.0
3.42
6496
47702
(3011985) Renin [Units/volume] in Plasma
142
1447
0.67
5.07
1.2
1.4
mu/l
50.3
56.9
0.19
118
1271
(3001604) Monocytes [#/volume] in Blood
7561
54409
0.93
5.05
4.8
5.6
e9/l
0.6
0.6
0.00
6404
45815
(1616796) Gas panel - Central venous blood
563
3177
1.23
5.01
3.1
3.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
611
3478
1.22
5.00
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
133
1367
0.67
4.97
1.5
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
885
5214
1.18
4.97
3.7
4.2
mmol/l
25.1
24.9
1.57
756
4777
(3018010) Neutrophils/100 leukocytes in Blood
7163
51595
0.93
4.87
5.2
5.8
%
60.6
59.0
19.86
6458
47520
(3010813) Leukocytes [#/volume] in Blood
16257
110309
1.09
4.85
29.7
27.2
e9/l
7.2
6.9
17.57
15554
106238
(3048929) Epstein Barr virus Ab [Presence] in Serum
176
1710
0.71
4.85
1.1
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
40
558
0.49
4.85
1.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
1047
6265
1.16
4.84
3.0
3.9
mmol/l
24.3
24.1
0.82
931
5595
(40767503) Oxygen content in Capillary blood by calculation
536
3022
1.23
4.82
2.4
2.6
%
16.3
15.7
2.42
256
1646
(3048689) Calprotectin [Mass/mass] in Stool
1312
10226
0.88
4.81
1.8
2.0
ug/g
180.3
165.8
0.58
959
7773
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
132
1349
0.67
4.81
1.1
1.3
pmol/l
275.8
259.1
0.27
95
1027
(3013115) Eosinophils [#/volume] in Blood
7842
56282
0.94
4.75
5.0
5.8
e9/l
0.2
0.2
0.44
6699
48138
(3007461) Platelets [#/volume] in Blood
16247
110278
1.09
4.67
29.7
27.2
e9/l
236.8
239.0
3.76
15613
106669
(3035941) MCH [Entitic mass]
16248
110287
1.09
4.66
29.5
27.1
pg
30.4
30.4
0.63
15761
108129
(3032057) Clostridioides difficile [Presence] in Stool
80
324
1.71
4.66
1.5
1.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
16249
110296
1.09
4.65
29.7
27.2
e12/l
4.3
4.4
116.34
15544
106181
(3016502) Oxygen saturation in Arterial blood
2281
14369
1.11
4.64
4.7
6.6
%
95.0
95.3
1.00
2187
13807
(3024731) MCV [Entitic volume]
16248
110293
1.09
4.63
29.6
27.1
fl
92.0
91.8
2.45
15766
108133
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
33
97
2.35
4.63
1.1
1.2
pmol/l
20.2
17.0
0.19
28
84
(3027801) Oxygen [Partial pressure] in Arterial blood
2537
16069
1.10
4.63
4.6
6.4
kpa
11.3
11.8
4.95
2390
15226
(3000963) Hemoglobin [Mass/volume] in Blood
16250
110308
1.09
4.63
29.9
27.4
g/l
128.7
131.9
130.77
15764
108161
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
43
142
2.09
4.61
3.3
3.0
umol/l
36.7
41.0
0.59
38
113
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
433
3691
0.80
4.60
1.1
1.1
u/ml
1.6
1.2
0.31
13
52
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2538
16082
1.10
4.59
4.6
6.4
kpa
5.0
5.1
2.56
2395
15244
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
96
410
1.62
4.59
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
233
1189
1.36
4.57
2.3
2.3
u/field
2.5
2.3
0.09
71
431
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
52
655
0.55
4.57
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
52
655
0.55
4.57
1.3
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
10832
76876
0.94
4.56
4.7
4.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
44
581
0.52
4.53
1.0
1.0
u/ml
0.5
1.0
0.84
12
239
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
52
652
0.55
4.50
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
52
651
0.55
4.48
1.3
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
32
466
0.47
4.43
1.1
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
32
466
0.47
4.43
1.0
1.0
u/ml
0.2
1.2
—
8
116
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
91
984
0.64
4.40
1.0
1.1
%
118.8
115.2
0.45
79
851
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
53
655
0.56
4.38
1.3
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
2002
15139
0.90
4.37
4.4
5.1
%
34.7
33.7
3.08
1223
9702
(3000764) Benzodiazepines [Presence] in Urine
106
470
1.56
4.36
2.0
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
82
905
0.62
4.35
1.1
1.2
u/ml
99.4
78.5
—
5
43
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
211
1954
0.74
4.34
1.4
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
15
296
0.35
4.34
1.2
1.3
—
1.5
—
0
43
(3002030) Lymphocytes/100 leukocytes in Blood
7303
52426
0.94
4.33
5.4
6.1
%
24.1
25.5
19.79
6542
48043
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
116
1188
0.67
4.32
1.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
132
1318
0.69
4.30
1.2
1.3
nmol/l
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
53
651
0.56
4.29
1.3
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1895
11877
1.11
4.26
4.3
6.0
mmol/l
1.5
1.4
4.94
1806
11377
(3003888) Timothy IgE Ab [Units/volume] in Serum
47
596
0.54
4.26
1.0
1.0
u/ml
0.3
2.7
5.17
13
267
(3025130) Human papilloma virus identified in Specimen
45
578
0.54
4.26
1.8
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
2825
20990
0.92
4.25
4.1
4.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
152
0.23
4.23
1.4
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
106
475
1.54
4.18
2.0
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
144
688
1.45
4.17
1.7
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
223
2035
0.75
4.16
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
106
477
1.54
4.11
2.0
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
4042
29559
0.93
4.08
3.7
4.1
%
81.0
83.4
6.99
3909
28910
(46235355) HIV 1 and 2 tests - Meaningful Use set
1184
9185
0.88
4.07
1.4
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
70
787
0.61
4.05
1.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
172
0.28
3.97
5.0
4.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
139
1352
0.71
3.94
1.1
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
33
105
2.17
3.92
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
89
939
0.65
3.89
1.3
1.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
89
391
1.57
3.86
1.1
1.1
ng/l
72.7
477.5
1.79
11
111
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
74
810
0.63
3.84
1.1
1.2
titre
100.0
186.6
—
6
29
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
74
810
0.63
3.84
1.1
1.2
titre
190.0
129.7
0.32
15
145
(4306422)
98
1010
0.67
3.82
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
246
1303
1.31
3.82
1.7
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
170
0.28
3.82
1.1
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
69
766
0.62
3.81
1.0
1.2
%
94.9
92.2
0.36
59
702
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
26
384
0.47
3.81
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
1536
9580
1.11
3.80
5.3
4.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
634
3728
1.18
3.74
2.6
3.2
mmol/l
25.0
24.9
0.21
555
3273
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
118
1168
0.69
3.73
1.7
1.8
pmol/l
171.9
189.1
1.24
101
1067
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
113
1127
0.69
3.72
1.1
1.2
u/ml
4.6
4.9
0.05
35
381
(3028717) Thiamine [Mass/volume] in Blood
28
85
2.27
3.72
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
24
361
0.46
3.70
1.0
1.0
u/ml
1.9
2.0
—
10
147
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
333
2843
0.80
3.67
1.6
1.6
iu/ml
26.5
5.7
0.75
102
712
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
175
0.31
3.67
1.0
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
961
7500
0.88
3.66
5.7
7.7
mmol/l
24.4
24.4
0.07
860
6914
(3006184) Hemoglobin [Mass/volume] in Capillary blood
562
3278
1.19
3.66
2.1
2.3
g/l
128.0
126.1
1.04
432
2379
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
27
387
0.48
3.65
1.5
1.7
u/ml
312195.2
38014.8
—
5
62
(3051593) INR in Capillary blood by Coagulation assay
172
871
1.36
3.64
6.9
12.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
50
592
0.58
3.60
1.1
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
7781
55531
0.94
3.59
5.0
5.7
e9/l
1.8
1.9
1.98
6662
47618
(3023487) Leukocytes [#/volume] in Peritoneal fluid
35
458
0.53
3.59
1.5
1.9
e6/l
522.0
3944.3
1.03
22
314
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
129
1247
0.71
3.57
1.1
1.2
u/ml
277.2
287.6
0.15
72
755
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
29
401
0.50
3.54
1.2
1.4
pmol/l
53.5
129.0
0.57
16
140
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
90
926
0.67
3.52
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
184
0.34
3.52
1.3
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
9
184
0.34
3.52
1.2
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
184
0.34
3.52
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
185
0.34
3.51
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
185
0.34
3.51
1.3
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
61
250
1.68
3.50
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
99
999
0.68
3.50
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
278
2407
0.79
3.50
1.1
1.2
titre
540.0
926.3
—
6
78
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
30
408
0.51
3.48
1.5
1.8
e6/l
1977.7
14363.1
1.84
16
231
(3004616) Nuclear Ab [Presence] in Serum
137
1305
0.72
3.48
1.2
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
28
389
0.50
3.47
1.0
1.0
u/ml
0.9
2.0
0.62
12
161
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
254
2220
0.79
3.47
1.2
1.3
u/l
30.5
41.3
1.58
211
1916
(3003338) MCHC [Mass/volume]
11718
78973
1.06
3.43
27.7
24.9
g/l
330.2
330.9
12.01
11466
78238
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
53
609
0.60
3.42
2.1
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
1009
6182
1.13
3.41
3.4
4.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
158
0.31
3.41
1.1
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1669
12561
0.91
3.34
4.3
6.3
mmol/l
11.5
11.6
0.21
1510
11791
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
34
438
0.53
3.34
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
141
1327
0.73
3.34
1.3
1.3
u/l
11.8
11.9
0.03
106
1053
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
68
731
0.64
3.31
1.1
1.1
—
36.6
—
0
5
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
18
288
0.43
3.31
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
18
288
0.43
3.31
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
18
288
0.43
3.31
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
18
288
0.43
3.31
1.2
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
78
346
1.56
3.30
1.1
1.1
u/l
1.1
1.1
0.19
37
174
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
112
1092
0.71
3.30
1.1
1.2
u/ml
5.6
4.3
0.27
41
487
(3010370) Gastrin [Moles/volume] in Serum or Plasma
8
165
0.33
3.26
3.4
1.4
pmol/l
66.2
58.4
—
8
126
(4268621)
67
720
0.64
3.26
2.0
2.3
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
24
73
2.27
3.21
1.1
1.4
%
46.9
43.3
0.14
19
43
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
104
1020
0.70
3.18
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
23
330
0.48
3.17
1.2
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
66
706
0.64
3.16
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
152
0.32
3.14
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
153
0.32
3.13
1.1
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
12
25
3.31
3.12
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
169
1530
0.76
3.09
3.2
3.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
37
451
0.56
3.03
2.4
2.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
281
2381
0.81
2.97
1.1
1.1
titre
109.1
138.8
0.53
22
170
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
196
0.35
2.97
1.2
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
68
711
0.66
2.95
1.2
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
33
119
1.91
2.91
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
19
282
0.46
2.91
1.2
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
12
214
0.39
2.90
2.6
2.5
u/l
726.2
1110.0
0.24
12
200
(3023520) Reticulocytes [#/volume] in Blood
2022
12957
1.08
2.89
2.1
2.5
e9/l
65.3
67.9
2.78
1583
9851
(3007147) Virus identified in Stool by Electron microscopy
7
8
6.04
2.88
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
11520
81095
0.95
2.88
24.7
22.6
%
14.0
14.0
0.84
11182
79208
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
146
0.33
2.86
1.4
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
10
192
0.36
2.85
1.0
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
5498
39418
0.95
2.84
4.6
5.6
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
33
406
0.56
2.83
7.1
3.7
u/ml
49.7
57.0
—
7
48
(3038071) Oxygen [Partial pressure] in Mixed venous blood
16
250
0.44
2.82
7.6
8.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2596
19032
0.93
2.77
1.2
1.2
u/ml
1.8
1.8
0.02
602
4432
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
64
666
0.66
2.74
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
35
419
0.58
2.73
1.7
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
53
573
0.64
2.72
4.8
6.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
223
1915
0.80
2.71
1.4
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1772
11327
1.09
2.70
1.7
2.1
g/l
0.2
0.2
1.00
1545
10457
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
75
754
0.68
2.69
3.9
5.0
u/ml
15.6
105.9
3.59
13
221
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
96
924
0.72
2.69
1.3
1.2
mmol/l
7.6
8.0
0.46
71
613
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
34
129
1.82
2.61
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
264
2215
0.82
2.58
1.6
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
2018
12998
1.08
2.55
5.0
7.0
g/l
120.3
119.3
1.49
1954
12523
(40768446) Kidney Pathology biopsy report
25
322
0.53
2.54
1.1
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
283
2353
0.83
2.53
1.5
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
189
1639
0.79
2.53
1.5
1.5
%
66.4
62.6
0.74
124
1024
(3027944) Amphetamines [Presence] in Urine
94
461
1.41
2.52
2.0
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
233
1973
0.81
2.51
1.6
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
39
442
0.61
2.48
1.2
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
217
0.44
2.46
1.8
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
508
4015
0.87
2.45
1.9
2.4
g/l
0.0
0.0
0.00
433
3667
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
78
2.03
2.44
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
49
212
1.60
2.40
1.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
26
93
1.93
2.39
1.0
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
305
2500
0.84
2.36
1.3
1.5
g/l
30.5
31.5
0.71
277
2221
(3011412) CD3 cells [#/volume] in Blood
98
917
0.74
2.35
2.3
2.0
e9/l
1.1
1.1
0.13
61
560
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
132
0.37
2.34
1.4
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
239
2001
0.82
2.33
1.3
1.5
e6/l
79453.3
62475.9
0.35
156
1179
(3020393) Adenovirus Ag [Presence] in Stool
28
104
1.86
2.32
1.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
16
230
0.48
2.31
1.2
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
17
52
2.26
2.31
1.4
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
75
730
0.71
2.31
1.3
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
75
730
0.71
2.31
1.3
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
17
239
0.49
2.30
1.5
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
36
407
0.61
2.30
2.2
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
705
5431
0.89
2.30
2.6
2.7
u/ml
0.4
0.3
0.32
412
3116
(3023323) Follitropin [Units/volume] in Serum or Plasma
95
889
0.74
2.29
1.6
1.4
iu/l
37.7
33.1
0.53
80
748
(3044007) Cell count panel - Peritoneal fluid
31
363
0.59
2.28
1.7
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
136
1209
0.77
2.27
1.6
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
81
776
0.72
2.27
1.5
1.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
13
200
0.45
2.26
5.2
7.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
355
2861
0.85
2.26
2.2
2.7
mg/l
1.8
1.8
0.48
293
2534
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
101
514
1.36
2.22
1.1
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
128
675
1.31
2.22
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
128
675
1.31
2.22
1.2
1.4
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
67
317
1.46
2.22
1.3
1.5
pmol/l
15.9
17.1
0.80
52
252
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
13
198
0.45
2.21
1.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
106
0.33
2.20
2.4
1.5
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
210
1178
1.23
2.20
1.7
1.6
u/ml
30.2
25.2
0.72
51
240
(3012441) Differential panel - Pleural fluid
227
1898
0.82
2.20
1.4
1.5
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
101
930
0.75
2.20
1.2
1.4
g/l
2.9
2.9
0.03
71
638
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
6
118
0.35
2.20
1.0
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
108
0.32
2.19
2.8
4.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
101
929
0.75
2.19
1.2
1.4
g/l
0.5
0.4
0.12
71
638
(3027135) IgG subclass 1 [Mass/volume] in Serum
101
929
0.75
2.19
1.2
1.4
g/l
7.4
7.2
0.21
68
635
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
57
262
1.50
2.18
1.1
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
157
1363
0.79
2.17
1.1
1.2
u/l
60.2
60.7
0.03
92
906
(3014576) Chloride [Moles/volume] in Serum or Plasma
2613
17083
1.06
2.17
4.8
6.3
mmol/l
104.5
104.3
1.46
2522
16691
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
161
1392
0.80
2.16
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
24
296
0.56
2.15
6.9
8.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
70
680
0.71
2.15
2.0
1.8
%
14.0
16.1
0.57
31
251
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
523
4082
0.88
2.14
1.9
2.4
g/l
0.0
0.0
0.06
435
3679
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
148
0.42
2.11
1.2
1.1
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
7
124
0.39
2.08
3.4
2.3
umol/l
191.1
365.0
—
7
115
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
215
1794
0.82
2.07
1.2
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
128
684
1.29
2.04
1.1
1.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
73
697
0.72
2.04
2.0
1.8
%
72.7
69.8
0.78
67
654
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
89
824
0.74
2.04
2.9
3.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
465
2815
1.14
2.04
2.4
2.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
86
434
1.37
2.02
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
3911
28059
0.95
2.01
5.7
6.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
445
3493
0.88
2.01
1.3
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
340
2015
1.17
2.00
1.1
1.1
u/ml
5.4
12.9
—
9
98
(3019977) pH of Arterial blood
151
827
1.26
1.99
2.1
2.4
ph
7.4
7.4
0.08
35
342
(3028679) Herpes simplex virus Ab [Presence] in Serum
64
308
1.43
1.98
1.1
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
24
90
1.84
1.97
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
35
382
0.63
1.97
1.3
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
36
390
0.64
1.96
1.1
1.1
—
—
—
0
0
(3013512) EKG study
5609
37495
1.04
1.96
4.8
4.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
287
2321
0.85
1.96
3.0
3.4
%
2.0
1.4
1.01
206
1787
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
13
188
0.48
1.95
1.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
69
659
0.72
1.95
2.1
1.9
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
11
169
0.45
1.95
1.7
1.7
—
—
—
0
0
(4062490)
103
927
0.77
1.95
1.2
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
80
746
0.74
1.94
2.1
1.9
%
41.1
39.5
0.15
13
88
(3037556) Urate [Mass/volume] in Serum or Plasma
39
414
0.65
1.94
1.5
1.5
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
99
0.35
1.93
1.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
145
1250
0.80
1.93
1.2
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
1166
8679
0.92
1.92
5.8
7.8
%
93.0
93.7
3.35
1157
8647
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
233
1913
0.84
1.91
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
232
1338
1.20
1.90
2.7
2.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
161
1368
0.81
1.89
1.0
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
5350
38054
0.96
1.88
2.4
2.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
565
4347
0.89
1.86
1.8
2.3
g/l
0.1
0.0
0.12
475
3927
(3028626) Oxygen [Partial pressure] in Capillary blood
532
3273
1.12
1.84
2.5
2.9
kpa
7.6
7.8
2.63
487
3033
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
51
507
0.69
1.84
1.1
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
173
1454
0.82
1.83
2.9
3.4
%
59.8
59.3
0.09
97
919
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
33
357
0.64
1.81
2.2
1.8
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
107
0.39
1.81
1.3
1.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
190
0.51
1.77
10.6
12.9
mmol/l
5.6
5.2
0.42
14
190
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
64
607
0.73
1.76
1.3
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
500
3858
0.89
1.76
1.6
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
203
1671
0.84
1.74
1.4
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
86
779
0.76
1.74
1.1
1.1
u/ml
3.4
4.7
0.32
18
176
(3029634) Reagin Ab [Titer] in Serum by VDRL
151
845
1.23
1.70
1.4
1.7
—
2.8
—
0
12
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
82
744
0.76
1.69
2.1
2.2
ug/min
388.6
113.8
0.37
16
183
(3003740) Influenza virus B Ag [Presence] in Specimen
56
538
0.72
1.69
1.1
1.1
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
17
60
1.95
1.68
1.5
1.6
mmol/l
25.4
22.6
1.49
12
33
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
19
70
1.87
1.67
1.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
63
593
0.73
1.67
1.8
2.2
ml
1689.6
1814.8
0.37
46
493
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
17
212
0.55
1.65
1.2
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
87
780
0.77
1.65
1.2
1.2
u/l
104.7
93.6
0.30
75
676
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
205
1676
0.84
1.65
1.2
1.3
u/l
355.0
439.6
0.70
192
1587
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
282
2245
0.86
1.63
1.2
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
401
3115
0.89
1.61
1.6
1.6
e6/l
18492.1
14649.9
0.61
289
2204
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
518
3965
0.90
1.60
1.1
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
92
815
0.78
1.60
1.9
2.1
min
517.1
498.2
1.27
63
569
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
100
876
0.79
1.59
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
200
1632
0.84
1.59
1.5
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
242
1943
0.86
1.57
1.2
1.4
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
30
0.00
1.57
0.0
1.7
—
1.9
—
0
20
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
30
0.00
1.57
0.0
1.0
—
0.1
—
0
19
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
144
1209
0.82
1.56
1.1
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
99
0.42
1.56
1.0
1.0
—
—
—
0
0
(44806420)
90
479
1.30
1.56
2.4
2.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
275
2184
0.87
1.55
1.3
1.5
e6/l
2980.2
2279.5
0.37
210
1575
(3036071) Salmonella sp Ab [Titer] in Serum
17
207
0.57
1.54
1.2
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
2433
17532
0.95
1.51
1.9
2.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
29
308
0.65
1.51
1.3
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
40
397
0.69
1.49
1.6
1.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
10
142
0.49
1.48
1.8
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
28
298
0.65
1.48
3.5
2.2
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
20
79
1.75
1.45
1.6
1.6
mmol/l
2.5
0.8
—
8
47
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
43
418
0.71
1.43
1.0
1.1
iu/ml
11.9
12.2
—
10
90
(3002523) Influenza virus A Ag [Presence] in Specimen
58
537
0.74
1.43
1.1
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
122
1029
0.82
1.41
1.7
1.9
ug/l
3.0
4.0
1.30
107
890
(3017509) Phencyclidine [Presence] in Urine
7
19
2.54
1.41
1.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
148
0.51
1.40
1.5
1.5
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
68
613
0.76
1.39
1.3
1.5
%
4.6
3.6
0.27
20
136
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
87
760
0.79
1.39
1.2
1.2
u/l
37.7
27.5
0.64
69
648
(3034426) Prothrombin time (PT)
23
251
0.63
1.38
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
72
643
0.77
1.38
2.3
2.0
e6/l
665.0
562.2
0.55
29
282
(36660697) Celiac disease serology panel - Serum
943
6970
0.93
1.38
1.2
1.2
—
—
—
0
0
(4015189)
45
430
0.72
1.37
1.6
2.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
137
0.50
1.36
1.4
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
67
602
0.77
1.35
2.2
2.0
e6/l
417.0
517.2
1.32
59
511
(3022948) Iron [Moles/volume] in Serum or Plasma
3189
21235
1.04
1.34
2.2
2.6
umol/l
11.2
11.9
5.83
2762
19473
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
37
175
1.46
1.34
3.5
2.7
u/field
0.5
0.5
0.00
37
175
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
15
56
1.85
1.31
1.5
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
22
238
0.64
1.29
1.2
2.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
232
1834
0.87
1.28
1.2
1.4
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
5
83
0.42
1.28
1.0
1.4
—
27521.6
—
0
5
(3020564) Creatinine [Moles/volume] in Serum or Plasma
15752
107800
1.04
1.27
23.5
22.1
umol/l
85.4
85.2
0.15
15745
107743
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
26
270
0.66
1.26
1.0
1.1
%
86.3
93.9
0.58
21
193
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
27
121
1.54
1.26
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
48
242
1.37
1.24
1.1
1.1
miu/ml
1711.4
1694.6
0.03
48
242
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
14
52
1.86
1.24
1.0
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
144
834
1.19
1.24
1.9
2.2
mmol/l
7.6
7.2
0.80
103
563
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
65
578
0.77
1.23
1.6
1.5
u/l
5.2
6.6
2.33
52
467
(3044927) Protein electrophoresis panel - Urine
272
1655
1.14
1.23
1.2
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
156
911
1.18
1.22
1.3
1.2
nmol/l
1.2
1.4
2.76
142
819
(3002331) Protein [Mass/volume] in Peritoneal fluid
29
292
0.68
1.21
1.4
1.3
g/l
24.5
47.4
0.63
20
238
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
249
1949
0.88
1.21
1.8
2.2
pg
33.1
32.6
1.05
244
1933
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
38
363
0.72
1.19
2.4
2.0
u/l
18.7
44.9
2.19
33
340
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
25
0.00
1.18
0.0
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
23
241
0.66
1.18
1.1
1.3
%
109.8
115.2
0.44
17
207
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
23
241
0.66
1.18
1.2
1.1
%
78.0
81.7
—
7
125
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
150
1216
0.85
1.18
1.4
1.5
%
20.2
27.3
2.27
95
752
(3026692) Albumin [Mass/volume] in Peritoneal fluid
33
322
0.71
1.17
1.2
1.4
g/l
13.8
15.0
0.30
22
250
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
5
13
2.65
1.17
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
147
0.56
1.16
1.5
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
294
2271
0.89
1.16
1.3
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
40
377
0.73
1.16
1.1
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
167
1339
0.86
1.15
1.2
1.3
u/l
20.6
12.2
1.49
147
1231
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
17
189
0.62
1.14
1.8
4.3
u/l
39.7
42.4
0.18
11
67
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
23
239
0.66
1.14
1.2
1.2
%
97.6
79.4
—
7
127
(3000093) Morphology [Interpretation] in Blood Narrative
172
1375
0.86
1.14
1.1
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
203
1603
0.87
1.14
1.3
1.4
mmol/l
6.1
6.4
0.91
182
1488
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
11
137
0.55
1.13
1.0
3.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
31
303
0.71
1.12
1.1
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
139
1128
0.85
1.12
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
139
1128
0.85
1.12
1.3
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
139
1128
0.85
1.12
1.3
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
94
790
0.82
1.11
1.5
1.6
u/l
4.1
7.3
1.66
42
372
(3001186) Copper [Moles/volume] in Serum or Plasma
31
148
1.45
1.11
1.2
1.1
umol/l
16.4
16.5
0.00
26
133
(3034860) Kappa light chains.free [Mass/volume] in Serum
704
5206
0.93
1.10
2.2
3.2
mg/l
55.6
79.2
1.13
542
4241
(3027923) C peptide [Moles/volume] in Serum or Plasma
95
537
1.22
1.08
1.3
1.3
nmol/l
1.1
1.2
0.07
65
408
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
87
0.48
1.07
1.5
4.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
14
55
1.76
1.07
1.3
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
193
0.64
1.05
1.1
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
704
5195
0.93
1.05
2.2
3.2
mg/l
49.0
49.0
0.00
545
4231
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
31
298
0.72
1.04
2.8
2.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
21
217
0.67
1.04
1.2
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
85
478
1.23
1.03
1.9
1.8
nmol/l
13.7
14.7
0.59
74
437
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
158
0.61
1.02
1.1
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
122
991
0.85
1.02
1.7
2.0
ug/l
1.8
2.3
1.74
96
821
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
120
976
0.85
1.02
1.1
1.1
iu/ml
0.8
2.3
—
7
49
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
57
306
1.29
1.02
2.8
2.5
mmol/l
7.5
7.8
0.32
41
200
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
80
675
0.82
1.01
1.1
1.1
u/l
27.8
30.4
0.17
55
481
(4024509)
217
1324
1.13
1.00
1.5
1.7
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
22
0.00
0.99
0.0
1.1
—
1921.8
—
0
22
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
277
2123
0.90
0.99
2.6
3.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
80
673
0.82
0.99
1.1
1.1
u/l
78.8
91.4
0.93
61
496
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
285
2180
0.90
0.99
1.6
1.6
iu/l
2.8
4.8
6.49
75
629
(4146454)
204
1589
0.88
0.97
2.5
2.7
—
—
—
0
0
(44813793)
61
524
0.80
0.93
1.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
22
102
1.49
0.93
16.4
10.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
12703
86813
1.03
0.93
22.6
20.2
%
36.6
38.0
24.60
6554
51377
(3016650) Hepatitis A virus Ab [Presence] in Serum
162
1276
0.87
0.93
1.1
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
32
160
1.38
0.93
1.1
1.3
ng/l
2928.5
181.0
0.50
20
109
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
46
244
1.30
0.92
2.7
1.5
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
73
0.47
0.91
1.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
31
290
0.74
0.91
1.9
2.2
ug/l
3.2
3.5
0.19
15
112
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
91
0.53
0.90
1.0
1.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
19
86
1.52
0.90
1.1
1.1
mmol/l
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
1575
10437
1.04
0.89
1.9
2.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
12
48
1.72
0.89
1.0
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
13
143
0.63
0.88
1.0
1.1
iu/ml
3.7
20.1
—
6
59
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
62
527
0.81
0.87
1.3
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
62
527
0.81
0.87
1.3
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
99
804
0.85
0.87
1.3
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
57
314
1.25
0.86
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
263
2002
0.90
0.86
1.3
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
13
54
1.66
0.85
1.3
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
67
563
0.82
0.85
1.2
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
76
630
0.83
0.84
1.2
1.1
iu/ml
2.6
4.5
—
5
35
(3027035) Albumin [Mass/time] in 24 hour Urine
10
116
0.59
0.84
1.4
1.3
—
743.8
—
0
13
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
99
801
0.85
0.84
1.3
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
770
5611
0.94
0.83
1.9
2.3
g/l
10.2
10.3
0.16
570
4612
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
162
986
1.13
0.82
1.3
1.3
titre
257.8
451.2
0.83
27
92
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
115
0.60
0.82
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
257
1952
0.91
0.82
1.5
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1020
7371
0.95
0.81
6.2
8.6
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
18
0.00
0.81
0.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
18
0.00
0.81
0.0
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
18
0.00
0.81
0.0
6.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
427
2733
1.08
0.81
2.3
2.7
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
32
1.72
0.81
1.8
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
295
1860
1.10
0.80
2.1
2.2
mg/l
30.5
28.2
0.23
80
454
(3036048) Francisella tularensis Ab [Titer] in Serum
21
204
0.71
0.79
1.0
1.2
—
1344.0
—
0
10
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
6727
45699
1.02
0.79
4.8
5.9
ug/l
5.0
4.5
0.24
5710
40281
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
63
527
0.82
0.78
2.4
2.6
%
42.2
36.7
0.81
23
191
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1481
10603
0.96
0.78
2.3
2.4
u/l
35.6
47.9
0.90
1209
9017
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
67
557
0.83
0.78
1.2
1.2
—
—
—
0
0
(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma
0
20
0.00
0.78
0.0
1.1
—
165.8
—
0
15
(3018291) Platelet Ab [Presence] in Serum
0
20
0.00
0.78
0.0
1.0
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
31
282
0.76
0.78
1.5
1.6
ug/l
90.6
114.0
0.69
25
237
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
9
35
1.77
0.78
1.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
28
258
0.75
0.77
1.1
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
692
5043
0.94
0.77
2.2
3.2
ratio
1.8
5.2
1.41
45
355
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
15557
107873
0.98
0.76
10.3
11.9
u/l
22.3
24.2
11.51
14607
102921
(3042517) Benzodiazepines panel - Urine
5
16
2.16
0.76
1.6
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
761
5523
0.95
0.74
1.9
2.3
g/l
3.1
3.1
0.72
518
4230
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
689
5013
0.95
0.73
1.9
2.5
g/l
1.2
1.1
0.19
517
4202
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
1012
7287
0.96
0.72
1.4
1.6
g/l
1.6
1.6
0.50
799
6215
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
265
1993
0.92
0.72
1.2
1.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1208
8664
0.96
0.72
5.6
7.7
%
0.7
0.7
4.63
1194
8600
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
159
1227
0.89
0.71
1.1
1.1
iu/ml
51.8
407.6
0.90
26
219
(3012494) Peanut IgE Ab [Units/volume] in Serum
14
143
0.67
0.71
1.0
1.1
u/ml
0.1
0.6
—
5
57
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
10
41
1.68
0.70
1.0
1.0
—
35.7
—
0
11
(3033923) Metanephrine [Moles/time] in 24 hour Urine
30
268
0.77
0.68
1.3
1.1
umol/24h
0.6
0.7
0.04
12
121
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
65
533
0.84
0.68
1.3
1.8
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
22
110
1.38
0.68
12.3
1.8
mmol/l
8.6
7.5
0.95
17
76
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
394
2908
0.93
0.68
1.3
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
12
125
0.66
0.67
1.2
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
42
359
0.81
0.67
1.3
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
825
5953
0.95
0.66
1.9
2.3
g/l
3.9
3.8
0.25
511
4158
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1214
8686
0.96
0.66
5.5
7.6
%
1.5
1.3
6.20
1200
8622
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
120
934
0.89
0.64
1.2
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
155
960
1.11
0.64
1.3
1.3
titre
49.0
65.1
—
10
85
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
85
677
0.87
0.64
1.2
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
85
677
0.87
0.64
1.2
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
85
677
0.87
0.64
1.2
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
27
241
0.77
0.63
2.0
1.6
ug/l
9.7
9.7
0.01
27
241
(3044941) Cell count panel - Synovial fluid
268
1999
0.92
0.63
1.4
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
828
5964
0.96
0.62
1.9
2.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
772
5088
1.05
0.62
2.1
2.0
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
14
0.00
0.62
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
106
0.65
0.62
1.6
1.5
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
16
0.00
0.60
0.0
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
119
921
0.89
0.60
1.1
1.2
miu/ml
143.5
209.3
0.74
15
252
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
830
5969
0.96
0.59
1.9
2.3
g/l
7.5
7.5
0.11
527
4322
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
12
121
0.68
0.59
1.0
1.2
umol/24h
1.7
1.7
0.02
12
121
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
496
3610
0.95
0.58
1.7
1.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
47
389
0.83
0.58
1.1
1.1
ratio
1.1
1.1
1.01
15
120
(3048879) Bone marrow aspiration report
59
478
0.85
0.57
1.2
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
86
676
0.88
0.56
2.9
3.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
44
365
0.83
0.56
1.1
1.2
—
—
—
0
0
(4212803)
17
159
0.74
0.56
1.1
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
9
40
1.55
0.56
1.3
1.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
115
708
1.12
0.55
2.0
2.0
umol/l
16.7
28.7
0.93
14
67
(3013293) Extractable nuclear Ab [Presence] in Serum
15
143
0.72
0.55
1.8
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
153
1161
0.91
0.55
2.0
2.2
ml
651.9
659.0
0.07
88
739
(3000991) Gas panel - Venous blood
1612
11429
0.97
0.55
5.0
7.1
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
11
50
1.52
0.54
1.1
1.0
pmol/l
208.4
169.7
—
5
28
(4133840)
20
181
0.76
0.53
1.4
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
92
0.67
0.53
1.0
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
641
4619
0.96
0.52
1.8
2.3
g/l
36.7
36.9
0.37
471
3868
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
33
279
0.82
0.51
1.2
1.1
pmol/l
275.3
272.0
0.02
19
192
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
405
2642
1.06
0.51
1.3
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
18
92
1.35
0.51
1.1
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
18
92
1.35
0.51
1.1
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
18
92
1.35
0.51
1.1
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
46
266
1.19
0.51
1.6
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
352
2574
0.94
0.51
1.5
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
96
589
1.12
0.50
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
53
427
0.86
0.50
1.3
1.3
u/l
34.5
32.8
0.13
38
352
(3022493) Free Hemoglobin [Mass/volume] in Plasma
67
530
0.87
0.50
1.1
3.1
mg/l
61.7
73.8
0.81
38
363
(3011648) Oxygen content in Venous blood
113
865
0.90
0.50
1.3
1.7
%
9.7
10.8
1.78
113
865
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
19
99
1.32
0.49
1.1
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
87
675
0.89
0.49
1.2
1.6
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
74
580
0.88
0.49
1.4
1.4
%
3.0
2.4
0.26
58
482
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
65
514
0.87
0.49
1.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
237
1524
1.07
0.48
1.4
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
86
666
0.89
0.47
1.3
1.4
%
60.4
66.7
0.87
65
542
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
63
498
0.87
0.47
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
27
149
1.25
0.47
1.2
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
10
99
0.70
0.47
1.0
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
118
737
1.10
0.47
2.4
2.0
u/field
2.5
2.4
0.01
77
488
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
146
0.76
0.47
1.6
1.6
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
12
58
1.43
0.46
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
535
3851
0.96
0.45
2.2
3.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
1054
7054
1.03
0.44
3.4
3.2
e9/l
4.3
4.2
0.59
666
4857
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
28
157
1.23
0.43
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
178
1139
1.08
0.43
1.3
1.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
166
1235
0.93
0.42
1.6
1.9
g/24h
1.4
0.7
—
8
38
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
11
0.00
0.42
0.0
1.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.42
0.0
1.1
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.42
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
40
1.38
0.41
1.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
99
753
0.91
0.41
1.5
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4591
32046
0.98
0.41
2.7
3.2
u/l
34.9
36.6
0.50
4226
29983
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
13
0.00
0.40
0.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
108
679
1.10
0.40
1.9
2.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
29
239
0.84
0.38
1.2
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
25
141
1.22
0.38
2.8
6.0
—
—
—
0
0
(3001729) Color of Synovial fluid
21
116
1.25
0.38
1.5
1.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
116
1.25
0.38
1.1
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
35
283
0.85
0.38
1.4
1.5
%
11.1
9.8
0.08
13
144
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
32
260
0.85
0.37
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
10
94
0.73
0.37
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
61
472
0.89
0.36
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
61
472
0.89
0.36
1.0
1.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
51
399
0.88
0.36
1.6
1.5
nmol/l
0.2
0.2
0.91
38
290
(3037121) Protein [Mass/volume] in Urine
681
4547
1.03
0.36
2.4
2.9
g/l
0.3
0.3
0.42
235
1891
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
33
193
1.18
0.36
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
892
6324
0.97
0.36
2.5
2.9
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
6
29
1.43
0.36
1.5
1.4
nmol/l
503.6
412.0
—
6
29
(3003327) Ova and parasites identified in Stool by Light microscopy
372
2680
0.96
0.36
1.6
1.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
52
316
1.14
0.35
1.4
1.5
ug/l
0.4
0.4
0.26
26
183
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
128
817
1.08
0.35
1.1
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
165
1215
0.94
0.35
1.3
1.4
u/l
13.2
13.5
0.16
155
1165
(3025468) Yersinia sp identified in Specimen by Organism specific culture
242
1581
1.06
0.35
1.3
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
27
221
0.84
0.34
1.7
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
105
786
0.92
0.34
1.1
1.2
—
—
—
0
0
(44806118)
169
1242
0.94
0.34
1.2
1.3
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
6
31
1.33
0.34
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
206
1504
0.94
0.34
3.5
3.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2952
20631
0.98
0.33
2.3
2.9
mmol/l
0.8
0.8
0.02
2604
18987
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
250
1638
1.05
0.33
1.3
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
21
175
0.83
0.32
2.6
2.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
47
366
0.89
0.32
1.7
1.8
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
35
278
0.87
0.32
1.9
1.8
%
10.5
12.0
0.17
29
246
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
241
1580
1.05
0.32
1.3
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
100
636
1.08
0.31
1.4
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
495
3532
0.97
0.31
1.1
1.1
titre
206.5
210.9
0.01
17
66
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
40
314
0.88
0.31
1.2
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
31
248
0.86
0.31
1.3
1.2
mu/l
40.5
78.9
1.60
20
177
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
11
57
1.33
0.31
1.0
1.1
—
—
—
0
0
(44790048)
170
1242
0.94
0.30
1.2
1.3
—
—
—
0
0
(44790047)
170
1242
0.94
0.30
1.2
1.3
—
—
—
0
0
(44790049)
170
1242
0.94
0.30
1.2
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
241
1584
1.05
0.30
1.3
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
8
76
0.73
0.29
1.1
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
8
77
0.72
0.29
1.1
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
8
77
0.72
0.29
1.1
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
25
202
0.85
0.29
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
67
506
0.91
0.28
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
211
1528
0.95
0.28
3.6
3.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
9
83
0.75
0.28
1.7
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
161
1173
0.95
0.27
1.2
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
273
1962
0.96
0.27
1.3
1.4
nmol/l
0.8
0.8
0.27
209
1604
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
898
6059
1.02
0.26
2.3
2.5
au/ml
45.7
30.4
0.63
13
170
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
19
156
0.84
0.26
1.7
1.3
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
67
423
1.09
0.26
5.6
5.1
%
62.3
72.7
1.94
53
330
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2687
18750
0.99
0.26
2.3
2.6
%
20.6
21.1
1.23
2051
15821
(3024869) Neuronal Ab [Presence] in Serum
41
252
1.12
0.26
1.0
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
9
49
1.27
0.26
1.1
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
48
298
1.11
0.26
2.0
2.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
101
650
1.07
0.26
1.0
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
57
0.73
0.24
8.5
8.4
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
34
264
0.89
0.24
3.1
2.8
ml/dl
15.4
14.6
0.83
28
246
(3025315) Body weight
11
95
0.80
0.24
7.1
5.3
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
19
154
0.85
0.24
1.1
1.2
mmol/l
7.0
6.5
—
7
69
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1841
12866
0.99
0.23
2.1
2.6
umol/l
9.4
9.8
0.25
1527
11217
(3018851) Theophylline [Moles/volume] in Serum or Plasma
26
156
1.15
0.23
1.3
1.7
umol/l
43.0
46.9
0.38
26
156
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
78
578
0.93
0.23
1.0
1.0
mg/l
294.9
290.6
0.19
64
506
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
18
146
0.85
0.23
2.0
2.0
ug/l
3.8
9.8
0.62
11
85
(3041918) Cholesterol [Moles/volume] in Pleural fluid
41
313
0.90
0.23
1.0
1.2
mmol/l
1.4
1.5
0.22
27
194
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
80
514
1.07
0.22
1.8
1.7
u/l
2188.1
1216.3
0.23
21
192
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
204
1467
0.96
0.22
1.3
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
28
1.23
0.22
1.2
1.3
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
7
0.00
0.22
0.0
1.1
—
27.6
—
0
7
(3001218) Citrate [Mass/time] in 24 hour Urine
0
8
0.00
0.22
0.0
1.4
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.22
0.0
6.8
—
8.9
—
0
8
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
8
0.00
0.22
0.0
1.4
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
0
8
0.00
0.22
0.0
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
8
0.00
0.22
0.0
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
61
455
0.92
0.21
1.3
1.5
umol/l
17.7
11.4
0.30
46
315
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
29
1.19
0.21
1.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
8
71
0.78
0.21
1.0
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
63
469
0.93
0.21
1.2
1.2
g/l
39.3
40.3
0.27
33
231
(3013166) Neutrophils/100 leukocytes in Synovial fluid
63
402
1.08
0.21
1.3
1.4
%
75.7
59.9
4.32
45
345
(3021374) Sirolimus [Mass/volume] in Blood
0
9
0.00
0.21
0.0
6.8
—
6.5
—
0
9
(3009992) Blasts/100 cells in Bone marrow
0
9
0.00
0.21
0.0
1.7
—
15.0
—
0
9
(40761539) Cells [Type] in Urine sediment by Light microscopy
49
368
0.92
0.20
1.3
1.2
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
10
0.00
0.20
0.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
471
3330
0.97
0.20
2.0
2.3
ug/min
123.2
106.7
0.29
234
1886
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
21
166
0.87
0.20
1.0
1.5
—
46.8
—
0
10
(44786800) Granulocytes/100 leukocytes in Body fluid
39
244
1.10
0.20
1.3
1.4
%
22.2
21.3
0.06
25
192
(3035611) Eosinophils/100 leukocytes in Synovial fluid
17
100
1.17
0.19
1.5
1.8
%
1.3
0.8
0.27
12
80
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
72
530
0.94
0.19
1.3
1.3
ug/l
1001.7
189.1
0.86
41
285
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
72
465
1.07
0.19
1.7
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
42
316
0.92
0.19
1.1
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
116
761
1.05
0.19
1.2
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
17
101
1.16
0.18
1.8
1.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
85
620
0.95
0.18
4.3
4.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
27
167
1.12
0.17
1.2
1.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
5
47
0.73
0.17
1.4
1.1
nmol/l
173.4
299.6
—
5
47
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
239
1598
1.03
0.17
1.3
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
98
0.84
0.17
1.1
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
241
1612
1.03
0.17
1.3
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
33
207
1.10
0.17
2.6
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
39
247
1.09
0.16
1.1
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
8
48
1.15
0.16
2.0
2.7
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
13
76
1.18
0.16
1.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
38
284
0.92
0.15
5.4
6.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
124
822
1.04
0.14
3.4
2.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
174
1239
0.97
0.14
1.2
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
3385
23479
0.99
0.13
1.6
1.7
mg/l
1.6
1.5
0.39
2617
18438
(3044009) aPTT.lupus sensitive (LA screen)
9
73
0.85
0.13
1.1
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
9
75
0.83
0.13
3.1
3.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
487
3414
0.98
0.12
1.3
1.6
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
43
316
0.94
0.12
1.3
1.3
%
30.3
32.0
0.10
27
205
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
1086
7565
0.99
0.12
2.5
2.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
173
1226
0.97
0.12
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
132
882
1.03
0.11
1.7
1.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
266
1796
1.02
0.11
5.9
6.1
mg/l
12.7
12.4
0.55
233
1618
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
433
3034
0.98
0.11
1.3
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2893
19844
1.01
0.11
2.2
2.6
g/l
2.2
2.3
3.76
2513
18201
(3014051) Protein [Presence] in Urine by Test strip
402
2729
1.02
0.10
2.6
2.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
67
482
0.96
0.10
2.2
2.7
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
22
165
0.92
0.10
2.2
1.8
e6/l
2804.6
1226.4
0.24
13
81
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
30
1.15
0.10
1.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
166
1172
0.98
0.09
2.3
1.8
mu/l
366.5
301.1
1.01
153
1077
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
31
228
0.94
0.09
1.2
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
15
93
1.11
0.09
1.1
1.1
u/l
10.2
9.4
0.12
15
93
(3024316) Viscosity of Plasma
10
60
1.15
0.09
2.1
1.8
mpas
1.6
1.8
—
5
40
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
48
346
0.96
0.08
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
108
725
1.03
0.08
2.0
2.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
7
45
1.07
0.08
1.4
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
96
681
0.97
0.08
1.1
1.2
mmol/l
11.6
12.1
0.21
37
213
(3017704) Immunofixation for Urine
122
862
0.98
0.08
1.2
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
50
0.83
0.08
1.2
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
31
202
1.06
0.07
1.5
1.2
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
14
106
0.91
0.07
2.1
1.8
%
76.7
61.6
—
9
69
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
15
113
0.92
0.07
1.3
1.0
—
—
—
0
0
(44806071)
13
81
1.11
0.07
1.2
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1821
12500
1.01
0.07
2.0
2.6
g/l
65.4
65.9
2.03
1502
11186
(3017315) Amylase [Enzymatic activity/volume] in Urine
82
581
0.97
0.06
1.2
1.2
u/l
180.3
318.9
1.60
73
533
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
785
5451
0.99
0.06
1.3
1.3
au/ml
43.6
61.3
1.40
32
228
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
30
217
0.95
0.05
1.3
1.4
%
76.1
74.7
0.09
23
184
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2520
17432
1.00
0.05
3.8
5.3
mmol/l
1.0
1.0
1.81
2217
15940
(3028433) Virus identified in Specimen by Culture
53
377
0.97
0.05
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
302
2102
0.99
0.04
2.9
3.2
e9/l
4.7
4.4
0.91
302
2096
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1129
7754
1.00
0.04
4.4
6.1
mmol/l
24.8
24.8
0.02
1111
7669
(3045716) Anion gap in Serum or Plasma
95
643
1.02
0.04
1.8
2.2
mmol/l
9.6
8.9
0.70
74
477
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
61
431
0.98
0.04
1.3
1.4
%
18.6
21.0
0.30
47
364
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
13
83
1.08
0.04
1.2
1.1
u/field
1.0
1.0
—
7
52
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
36
240
1.03
0.04
1.1
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
83
562
1.02
0.03
1.2
1.3
mmol/l
4.0
3.3
1.06
74
514
(3002621) Streptococcal DNAse B [Units/volume] in Serum
14
103
0.94
0.03
1.0
1.1
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
12
89
0.93
0.03
2.2
1.8
%
6.0
15.1
—
6
50
(3010144) Erythrocytes [#/volume] in Synovial fluid
175
1219
0.99
0.03
1.2
1.4
e6/l
155581.5
174781.5
0.11
110
836
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
11
70
1.08
0.03
2.1
1.2
u/field
1.4
1.0
—
5
41
(3006576) Bicarbonate [Moles/volume] in Blood
71
481
1.02
0.03
3.8
6.6
mmol/l
24.6
25.0
0.32
61
435
(3051651) Icteric interference index of Serum or Plasma
115
803
0.99
0.03
3.6
4.0
—
—
—
0
0
(3035880) pH of Pleural fluid
143
976
1.01
0.03
1.1
1.3
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
31
220
0.97
0.02
1.0
1.3
u/l
37.3
364.3
0.86
21
152
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
16
105
1.05
0.02
1.1
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
525
3610
1.00
0.01
1.4
1.4
ug/g
271.0
259.2
0.68
284
2247
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
260
1785
1.00
0.01
1.3
1.5
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
55
385
0.99
0.01
1.5
1.7
nmol/l
6.8
5.2
0.19
50
333
(4211845)
97
664
1.01
0.00
4.2
4.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
12
87
0.95
0.00
1.1
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
84
584
0.99
0.00
1.0
1.1
nmol/l
2.9
9.1
1.34
13
131
(3052851) Hemolysis interference index of Serum or Plasma
594
4091
1.00
0.00
3.7
3.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
55
375
1.01
0.00
1.4
1.9
mmol/l
1.8
0.6
2.02
46
356
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
10
73
0.94
0.00
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
19
127
1.03
0.00
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
24
163
1.02
0.00
1.5
1.3
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
27
183
1.02
0.00
1.1
1.3
ug/l
74.6
113.0
1.05
19
114
(3042010) Triglyceride [Moles/volume] in Pleural fluid
34
238
0.99
0.00
1.0
1.3
mmol/l
0.6
1.5
1.40
21
150
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
38
259
1.01
0.00
1.3
1.5
ng/l
103.9
129.0
1.00
38
259
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
24
167
0.99
0.00
1.0
1.2
u/l
16.1
17.6
0.23
14
118
(3025549) Creatine [Moles/time] in 24 hour Urine
17
117
1.00
0.00
1.3
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
14
99
0.98
0.00
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
795
5482
1.00
0.00
2.7
3.2
pmol/l
4.3
4.3
0.27
650
4730
(3002619) Bacteria identified in Specimen by Culture
36
245
1.01
0.00
1.3
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
46
320
0.99
0.00
1.1
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
39
269
1.00
0.00
1.2
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
19
133
0.99
0.00
1.4
1.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
169
1167
1.00
0.00
2.6
3.1
mg/l
49.2
38.8
0.28
124
852
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
10
72
0.96
0.00
1.2
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
72
1.05
0.00
1.1
1.3
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
11
72
1.05
0.00
1.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
5286
36450
1.00
0.00
4.4
5.0
%
21.7
22.5
3.44
2683
20238
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
5
38
0.91
0.00
1.0
1.1
—
0.1
—
0
17
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
34
1.01
0.00
1.0
1.2
nmol/l
21.5
31.7
—
5
28
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
34.8
—
0
5
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
40
0.86
0.00
1.0
1.2
—
—
—
0
0
(3011324) Intrinsic factor Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
135.9
—
0
5
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.8
—
0.4
—
0
6
(3008343) Lysozyme [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
22.9
—
0
6
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
50.6
—
0
5
(3009220) Epithelial cells.squamous [#/volume] in Urine sediment
0
5
0.00
0.00
0.0
1.2
—
3.4
—
0
5
(3049242) von Willebrand panel - Platelet poor plasma
5
34
1.01
0.00
1.2
2.1
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025504) Homovanillate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
47
0.88
0.00
1.0
4.7
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
5
37
0.93
0.00
1.2
1.4
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint F5_DEMENTIA_INCLAVO and mortality.

Females

Parameter HR [95% CI] p-value
F5_DEMENTIA_INCLAVO 2.557 [2.36, 2.77] < 0.001
Birth year 0.983 [0.98, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 125629 out of 199294 females with F5_DEMENTIA_INCLAVO died.

Males

Parameter HR [95% CI] p-value
F5_DEMENTIA_INCLAVO 2.722 [2.44, 3.04] < 0.001
Birth year 0.98 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 78758 out of 122214 males with F5_DEMENTIA_INCLAVO died.

Mortality risk

Mortality risk for people of age

years, who have F5_DEMENTIA_INCLAVO.

N-year risk Females Males
1 0.106% 0.363%
5 0.708% 1.942%
10 1.677% 4.878%
15 3.286% 8.802%
20 5.623% 14.153%

Relationships between endpoints

↥

Index endpoint: F5_DEMENTIA_INCLAVO – Dementia, including avohilmo

GWS hits: 40

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data